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ABSTRACT

KNOWLEDGE AND ATTITUDES REGARDING CERVICAL CANCER SCREENING
AMONG WOMEN LIVING WITH HIV/AIDS IN MALAWI:
A CROSS-SECTIONAL STUDY

May 2019

Jasintha T. Mtengezo, B.S.N.M., Kamuzu College of Nursing, Malawi
M.P.H., College of Medicine, Malawi
Ph.D., University of Massachusetts Boston
Directed by Professor Dr, Haeok Lee

Cervical cancer is the third most frequent cancer among women worldwide and about
265,672 women die from the disease annually. Abnormal cervical cells caused by human
papillomavirus are more common in HIV-positive women than in HIV-negative women due
to their compromised immune system. Malawi, in Sub-Saharan Africa, is one of the countries
with the highest rates of cervical cancer and HIV in the world. The incidence of cervical
cancer and deaths can be reduced by 80% if women go for screening. There are limited
studies about cervical cancer screening behavior, level of knowledge and attitudes regarding
cervical cancer and screening among Malawian HIV positive women. The purposes of this
Situation-Specific guided study were to determine the prevalence of cervical cancer
screening, level of knowledge and attitudes regarding cervical cancer and screening; and to
examine factors associated with screening behavior among Malawian HIV-positive women.
A cross-sectional survey was conducted with Malawian women living with HIV infection
aged 18-50 from HIV support organizations in one district in Malawi. Two stage
proportionate stratified cluster random sampling method was used to select 291 respondents.
iv

A face-to-face interviewer-administered survey was conducted after obtaining women‟s
informed consent. Data were analyzed using SPSS. Univariate descriptive statistics were used
to describe respondents‟ data. Bivariate and multivariate logistic regression models were used
to identify independent variables associated with cervical cancer screening. The adjusted
Odds Ratios (OR) and their corresponding 95% CI were used to measure the strength of
associations between knowledge and attitudes, and cervical cancer screening. A two-tailed pvalue of < .05 was considered statistically significant.
The prevalence of cervical cancer screening rate was 27.8% among 291 Malawi
women living with HIV infection. The findings showed that women had a high knowledge
level (M = 25.63, SD = 6.35) and positive attitude (M = 5.05, SD = 1.43) towards screening.
The factors independently associated with cervical cancer screening in HIV positive women
were occupation, OR = 5.12 (95% CI: 1.07, 24.43), knowledge OR =1.10 (95% CI: 1.02,
1.19), attitude, OR = 1.36 (95% CI: 1.04, 1.76), and access to screening services OR = 1.21
(95% CI: 1.01, 1.44). The cervical cancer screening rate among HIV positive women in
Malawi is still low. There is need for developing health education messages culturally
tailored to women living with HIV infection in Malawi to promote cervical cancer screening
uptake.
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CHAPTER 1
INTRODUCTION
This study assessed the cervical cancer screening rate, level of knowledge and
attitudes regarding cervical cancer and screening; and examined factors associated with
cervical cancer screening among Malawian HIV-positive women to prevent and control
cervical cancer among this at-risk population. The study is guided by the Situation-Specific
framework in the context of HIV positive women in Malawi developed from the findings of a
pilot qualitative study conducted by the researcher (Mtengezo & Lee, 2018). This chapter
provides the background of the problem, problem statement, significance of the study,
purpose of the study, research questions, aims of the study, preliminary study findings, and
conceptual framework used in the thesis.
Background
Cervical cancer is the third most frequent cancer among women worldwide and every
year 527,624 women are diagnosed with cervical cancer, and 265,672 of them die from the
disease (Ferlay et al., 2012). Eighty-five percent of cervical cancer cases and 87 % of the
cervical cancer deaths occur in less developed countries (WHO/ICO, 2010). Malawi as a
developing country and is one of the countries with the highest incidence rates of cervical
cancer and mortality in the world (Ferlay et al., 2012). Evidence has revealed that from 2007
to 2010, cervical cancer was the most common type of cancer accounting for 45.4% of all
new cases of cancers among women in Malawi (Msyambodza et al., 2012). The cause of
most cervical cancers is human papillomavirus (HPV) infection and the disease is more likely
to occur in women over age 40 years (Malawi Ministry of Health [MOH], 2017). The HPV
slowly causes cellular changes called pre-cancerous lesions or cervical intraepithelial
neoplasia (CIN) in the surface tissue of the cervix before the development of cancer (Ferlay
et al., 2012). The CIN lesions are graded depending on severity: CIN I, CIN II, and III. The
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CIN I have low-grade squamous intraepithelial lesions which often clear up without
treatment. CIN II and III have high-grade squamous intraepithelial lesions which continue to
grow and eventually develop into cancer (Ferlay et al., 2012). However, women with HIVinfection experience more rapid progression to cervical cancer and have a higher risk of
developing the disease than do HIV-negative women, due to a compromised immune system
(Ferlay et al., 2012; UNAIDS, 2013; WHO, 2010). The National Center for infectious
diseases division of HIV/AIDS, classified cervical cancer as an AIDS-defining illness as it is
directly related with the deterioration of the immune system (Cichocki, 2017). After a woman
has developed cervical cancer, there are limited treatment options. The WHO recommends:
1) Primary prevention by giving HPV vaccinatiom for young adolescent women. 2)
Secondary prevention of early detection by screening and treatment of precancerous cervical
lesions. 3) Tertiary prevention by treating cervical cancer to reduce morbidity and mortality
(Ferlay et al., 2012).
Evidence has indicated that vaccinations are over 95% effective in preventing HPV
infection and minimizing the cervical cancer incidence (Arbyn, Xu, Simoens, & MartinHirsch, 2018). The Malawi Government started an HPV vaccination pilot project in 2013 in
two districts (Zomba and Rumphi) in the country and but has not yet been rolled out due to
insuffient funding (MOH, 2017). This vaccination program targeted 9-13 year old youths
prior to sexual debut (MOH, 2015). Cervical cancer screening was found to be associated
with overall mortality reduction rate of 83% if every woman attended screening frequently
(Landy, Pesola, Castanon, & Sasieni, 2016). Therefore, screening is important for all women
but it is particular important for women infected with HIV.
Malawi is a landlocked country in Sub-Saharan Africa (Refer to Attachment A) with a
population of approximately 17.9 million (MDHS, 2017). According to a 2010 WHO report,
about 86% of the countries‟ total population lives in the rural areas; 65% are living in poverty
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with 27% in extreme poverty (WHO, 2010). The country has a low life expectancy of 58
years for men and 60 years for women (WHO, 2010). Some of the contributing factors to low
life expectancy include communicable diseases including HIV/AIDS. Malawi‟s HIV
prevalence rate is among the highest in the world (8.8%), with infected women aged 15-49
estimated at 10.8% as compared to 6.4% among men (MDHS, 2017). Further, the WHO
report has also indicated that HIV prevalence is highest in women at age 40-44 (19.8%),
higher in women living in urban areas (22.7%) than women living in rural areas (10.5%). The
use of antiretroviral therapy has extended survival for women living with HIV/AIDS but
HIV-infected individuals are prone to opportunistic infections, cervical abnormalities, and
other sexually transmitted infections (UNAIDS, 2013). Delayed detection of HPV in HIVinfected women is linked to invansive, inoperable cervical cancer with higher mortality from
cervical cancer than from HIV/AIDS (Firnhaber et al., 2016; Kafuruki, Rambau, Massinde, &
Masalu, 2013; Reddy et al., 2015). The WHO report indicates that every year, 3,684 women
are diagnosed with cervical cancer in Malawi and over 2,300 die from the disease (Ferlay et
al., 2012, Masamba, 2015). The main risk factors for high cervical cancer incidence and
mortality in Malawi include high HIV (10.0%) and HPV (33.6%) rates, insufficient
prevention and treatment, delayed detection, and inadequate availability of healthcare
services (Masamba, 2015; MDHS, 2017; MOH, 2017). The other risk factors include early
onset of sexual intercourse, multiple sexual partners, increased parity, and co-mobidity of
sexually transmitted diseases (Gadduci, Barsotti, Cosio, Domenici, & Riccardo, 2011; MOH,
2017). Further, the Malawi Ministry of Health report has indicated that the low literacy rate
contributes to early marriage and early sexual practice, which is a contributing factor for
cervical cancer (MOH, 2017). The literacy rate is estimated at 75% for women and 83% for
men (MDHS, 2017). The United Nations Educational Scientific and Cultural Organizations‟
(UNESCO) 2015 report indicated that globally, 100 million children do not finish primary
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education. Education attainment is directly related to health-related behaviors and attitudes.
Individuals with high educational attainment can understand their health needs, read and
follow health care instructions, advocate for their health care and the health care of their
families. They can also communicate effectively with healthcare providers. In Malawi,
studies have reported that cultural practices may also contribute to school drop-out including
initiation ceremonies causing school absenteesism or the practice of early marriages
(Behrman, 2014). Therefore, cervical cancer and HIV/AIDS are considered priority diseases
in the health care delivery system of Malawi.
In Malawi, health care services are delivered by public and private sectors. The public
sector provides services free of charge while the private not-for-profit health facilities provide
services for free for some services such as antiretroviral therapy (ART), HIV care, under five
childhood vaccinations and charge user fees for other services (MOH, 2017. The services are
delivered at three levels that include primary, secondary, and tertiary levels, with these
services linked through a comprehensive referral system (Refer to Table 1).
Table 1
Levels of health care services in Malawi

Total Facilities

Role

Primary Level

Secondary Level

Tertiary Level

453 health centers,
dispensaries, health
posts
-Provide primary
health care services.

63 (28 District Hospitals and 35 CHAM
hospitals)

4 Central Hospitals

-Provide highly
specialized
services.

Personnel

-Medical assistants,
nurses and midwives

-Provide specialized services to patients
referred from the primary health care
level, through outpatient and inpatient
services and community health services.
-Obs/Gynae specialists, Medical Doctors,
clinical officers, nurses and midwives

VIA Services

-Encourage women
to go for VIA
-Perform VIA
-Refer to District
Hospital

-Perform VIA
-Perform Cryotherapy and LLETZ (takes
biopsy).
- Gynecologists perform Hysterectomy.
-Refer cancer suspects to Central Hospital
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-Specialists,
Medical Doctors,
clinical officers,
nurses and
midwives
-Perform VIA and
Cryotherapy
- Offers cancer
treatmentradiotherapy and
chemotherapy
(Gynecologists)

The primary level consists of community initiatives, health posts, dispensaries,
maternity facilities, health centers, community and rural hospitals. The primary level provides
promotive and preventive care for some curative services such as provision of ART for
HIV/AIDs, malaria, tuberculosis, and neglected diseases treatment. The services are provided
by community-based cadres such as Health Surveillance Assistants (HSAs), nurse
technicians, and medical assistants. The secondary levels are referral facilities from primary
level facilities. They include all district and mission hospitals where both inpatient and
outpatient services are provided by nurses, clinical officers, and medical officers. The tertiary
level consists of central hospitals that provide referral health services for their respective
regions for secondary level hospitals. They serve as training health facilities and they provide
a wide range of preventive, diagnostic, and therapeutic services.
Cervical cancer prevention and control strategies are done at all three levels of health
care services. There are 503 health facilities in Malawi (373 Government and 129 private or
Non-Governmental). In 2015, there were only 129 functional cervical cancer-screening sites
across the country and 32 (25%) had functional cryotherapy (MOH, 2017). Additionally,
there were 391 trained cervical cancer screening service providers of whom only 272 (69.6%)
were providing screening services.
Screening is a secondary prevention level of cervical cancer. It has the potential to
detect abnormal conditions that can be treated before cancer develops (WHO, 2010). There
are several types of screening tests for cervical cancer globally including liquid-based
cytology (Pap smear), HPV DNA testing, and visual inspection with acetic acid (VIA)
(WHO, 2010). The VIA was the initial screening test, and it was replaced by cervical
cytology because of its low specificity (Bhattacharyya, Nath, & Deka, 2015; WHO, 2010).
Specificity is the proportion of all those without the disease (cancer) that the VIA correctly
identifies as negatives. Low specificity results in resources being spent on unnecessary
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treatment of women who are free of precancerous lesions in a single visit approach. It is also
less accurate among post-menopausal women as the squamo-columnar junction cannot be
seen (Bhattacharyya et al., 2015). As such, the CDC (US) recommends that women aged 21–
65 be screened for cervical cancer and precancerous lesions by Pap smear testing every three
years due to its high sensitivity and specificity. The developed countries approach cervical
cancer prevention by screening for CIN and early invasive cervical cancers using the Pap
smear (CDC [US], 2016). However, there are infrastructure problems and insufficient human
and financial resources to implement the cervical cytology prevention approach in developing
countries (Ogunwale et al., 2016). Thus, over 80% of cervical cancer in sub-Saharan African
countries is diagnosed late (Ferlay et al., 2012). Studies indicated that VIA was useful and a
feasible alternative screening test for precancerous and cancerous lesions (Hasanzadeth,
Esmaeili, Tabaee, & Samadi, 2011; Kitchener & Symonds. 1999; McIntoch, 1999). Women
need access to screening services to address the burden of cervical cancer in resource limited
countries, therefore, the CDC recommends cervical cancer screening using VIA in
developing countries (WHO, 2010). The VIA has low and wide range of specificity (6495%) compared to Pap smear (93-98%) (Refer to Table 2).
Table 2
Differences between VIA and Pap Smear
Variable
Sensitivity
Specificity
Cost

VIA
65-89%
64-95%
$3.16-17.05/case

Providers

Nurses, clinicians, medical
officers and Obstetricians
Can be done in remote
places
30-50

Places
Age in
years
Safety
Practical
Affordable
Effective
Available

Yes
Yes
Yes
Yes
Yes

Pap Smear
52-80%
93-98%
$8.17187.52/case
Cytotechnologists
In hospitals
21-65
Yes
No
No
Yes
No
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Reference
(Bhattacharyya et al., 2015; CDC,
2010; Hasanzadeth et al., 2011;
Kitchener & Symonds, 1999. LinceDeroche, Phiri, Michelow, Smith, &
Firnhaber, 2015; McIntoch,
Blumenthal, & Blouse, 2001;
McIntoch, 1999).

The wide range of specificity (64-95%) between studies (Bhattacharyya et al., 2015;
Lince-Deroche, Phiri, Michelow, Smith, & Firnhaber, 2015; McIntoch, 1999) may be due to
the high incidence of suspected acetowhite epithelium, which might be inflammation,
immature metaplasia or latent HPV infection. This may also indicate the lack of skills and
knowledge of those performing the VIA and interpreting the results. There is need to train
nurses and clinicians at grassroots level to maximize the sensitivity and specificity of VIA.
The recent studies have demonstrated that both VIA and Pap smear tests are useful in
detecting CIN which is true precancerous lesions (Bhattacharyya et al., 2015; Hasanzadeth et
al., 2011; WHO, 2010). In addition, the VIA is most cost-effective at $3.16- $17.05 per true
CIN2+ case detected compared to Pap smear at $8.17-$187.52 depending on the country
(Bhattacharyya et al., 2015; Lince-Deroche et al., 2015). Therefore, the VIA approach is
recommended because it is less costly and much more practical to implement in resourcelimited settings (CDC, 2010; McIntoch, Blumenthal, & Blouse, 2001).
The VIA can be done by all trained health care providers including nurses and can be
done even in remote places within the community as it is minimally reliant on infrastructure
(Sankaranarayanan & Wesley, 2001). The VIA test is simple and easy to perform, test results
are available immediately, requires only one visit, can be integrated into primary health care
services, and is a suitable alternative to Pap smear to diagnose and prevent cervical cancer
lesion in resource limited countries (Sankaranarayanan & Wesley, 2001; McIntoch et al.,
2001). Pap smear screening is costly, needs infrastructure and trained manpower to make and
interpret the slides. Malawi has very few pathologists and oncology nurses and social workers
to offer the Pap smear approach, therefore, the VIA is the best approach.
Problem Statement
Evidence has shown that HIV-positive women are at higher risk of having precancerous lesions and progress faster to develop cervical cancer than HIV-negative women
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(Kamanga et al., 2013; Msyamboza, Phiri, Sichali, Kwenda, & Kachali, 2016; Sinayobye et
al., 2014; Ursu et al., 2015) (Refer to Table 3).
Table 3
Prevalence of Pre-cancerous Lesions
Author

Place of Study

CIN + in HIV-Positive
Women
14.4 - 33%

CIN + in HIV-Negative
Women
7 -7.3%

Kamanga et al., (2013);
Msyamboza et al., (2016)
Sub-Saharan Africa

Malawi

Hawes et al., (2003);
Moodley et al., (2006)
Sinayobye et al., 2014
Developed Countries
Whitham et al., (2017);
Ursu et al., (2015)

Senegal, South
Africa, Kenya,
Rwanda

34% - 50%

1.4% -13%

New York
Romania (Europe)

8.3- 45%

1.8- 35.2%

Women with HIV infection are about 2 to 5 times more likely to have pre-cancerous
lesions than HIV-negative women because: 1) HIV-infected women are more likely to have
persistent HPV infections. 2) Persistent HPV infection is a requisite in the progression of precancerous lesions to invasive cervical cancer (Ferlay, et al., 2012). This emphasizes that
cervical cancer screening is important for all women, but it is particularly a public health
priority among HIV-infected women worldwide.
Significance of the Study
Evidence has shown that Malawi has a high burden of cervical cancer and HIV rates
(Ferlay et al., 2012; MOH, 2017). The incidence of cervical cancer and deaths can be reduced
by 80% if coverage, quality, and follow-up of screening are high (Ferlay et al., 2012).
Vaccinations are also effective in preventing HPV infection but the program is not yet rolled
out in Malawi due to funding, therefore, screening is the only efficient way of early detection
and treatment of the pre-invasive cancer before it develops to disease. Malawi adopted the
VIA approach to screen for cervical cancer in 2004. Despite the availability of screening
services, the WHO report indicates that screening coverage for all women aged 18 and above

8

in Malawi was as low as 2.6% (WHO, 2010). Data from the WHO report is based on record
review and this could have missing information making the screening rate statistic unreliable.
However, a recent study has indicated that the cumulative screening rate for all
women in Malawi by 2015 was 26.5% and in HIV-positive women it was 15.9%
(Msyamboza et al., 2016). The Malawi cervical cancer screening guidelines recommend that
HIV-positive women should have annual cervical screening at their baseline evaluation,
thereafter, annually for those with normal results (MOH, 2005). Despite these
recommendations aimed at addressing HIV-positive women‟s increased risk of developing
cervical cancer, the screening rate is still low even though HIV positive women visit ART
clinics regularly. The possible reasons for the low screening rate may be due to the
availability of screening services that may not be integrated with ART; service providers are
not trained to do screening; clinics do not have equipment and supplies needed and other
reasons which need to be studied. The 2015 statistic is based on record review from the
National Cancer Control program and secondary data analysis is viewed as too subjective as
the information recorded from the reports may be incomplete as documents get misfiled.
Additionally, in Malawi health booklets are kept by individuals and sometimes people lose
them, thus affecting validity or truthfulness of the findings (Polit & Beck, 2011). There is no
empirical evidence to quantify HIV-positive women‟s screening rate, levels of knowledge
and attitudes regarding cervical cancer and screening; and factors associated with cervical
cancer screening among HIV-positive women in Malawi, hence, the significance of this
study. The results of this study will inform cancer screening programs to develop targeted
health education messages which will lead to behavioral modifications and prevention of
cervical cancer among HIV-positive women. Additionally, early detection of cervical cancer
can lead to a positive prognosis that can result in reduced health costs and alleviate the
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suffering of the individual HIV-positive women, their partners, families, and the population
at large.
Purpose of the Study
The study has two purposes: First, to determine the prevalence of cervical cancer
screening, the level of knowledge and attitude regarding cervical cancer and screening;
second, to determine factors associated with cervical cancer screening behavior among
Malawian HIV positive women.
Research Questions
The study answers the following the research questions:
1. What is the status of cervical cancer screening behavior, knowledge level and
attitudes regarding cervical cancer and screening among Malawian women with HIV
infection?
2. Is there a relationship between socio-demographic characteristics, knowledge,
attitude, social support networks, and access to health care and cervical cancer
screening behavior among Malawian women living with HIV infection?
Specific Aims
The specific aims to answer the above research questions include:
1. To describe cervical cancer screening behavior and level of knowledge and attitude
among Malawian women with HIV infection
2. To explore factors (socio-demographic characteristics, knowledge, attitudes, social
support networks, and access to health care) associated with cervical cancer screening
behavior among Malawian women living with HIV infection.
3. To examine whether knowledge and attitudes are independently associated with
cervical cancer screening after controlling for other determinants of cervical cancer
screening.
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Conceptual Model
The conceptual models and theories are sets of abstract concepts that are meant to be
generalized across populations (Fawcett & Garity, 2009). However, such generalizable
models and theories are not sufficiently specific to serve as evidence for the development of
practice guidelines (Meleis, 2012). Im and Meleis (1999) proposed that Situation-Specific
theory serves as evidence required for direct development of practice guidelines and
prescriptions for interventions for populations of interest. Therefore, the situation specific
theory was developed based on a preliminary qualitative pilot study by the researcher.
Preliminary Study Results
The qualitative pilot study was conducted to inform the current quantitative study as
there was no empirical evidence regarding knowledge and attitude about screening among
Malawian HIV infected women. The purpose of the pilot study was to explore barriers and
facilitators regarding cervical cancer screening among Malawian HIV-positive women. The
study was funded by the University of Massachusetts Boston, Office of Global Programs.
Data were collected through in-depth interviews with HIV-positive women aged 18 and
above. Thirteen participants were purposely selected from a hospital HIV clinic. For the
demographic characteristics of the participants in the pilot study, refer to Table 4.
Table 4
Preliminary Results: Demographic Characteristics
Variable
Cervical cancer Screening
Yes
No
Marital status
Married
Other
Source of
information
Fellow women
Multiple sources
Radio
HIV Clinic

11

n

%

2
11

15.4
84.6

6
7

46.2
53.8

6
3
2
2

46.1
23.1
15.4
15.4

Age in years
No. of children
No. of years since
HIV diagnosis

Mean (SD)
34.15 (8.87)
3.3 (2.59)

Range
22-52
0-8

5.23 (2.98)

1-11

Interviews were audiotaped, and field notes were taken. Data were analyzed using
thematic analysis (Braun & Clarke, 2006). The data were coded by the researcher and the
mentor independently to ensure conformability. The codes were compared and consensus was
reached for major themes from the study. The pilot study identified four factors influencing
cervical cancer screening behavior (Refer to Table 5).
Table 5
Pilot Study: Factors Influencing Screening
Major Themes
knowledge
regarding cervical
cancer and
screening

Subthemes
risk factors, signs and
symptoms, and
prevention of cervical
cancer

Attitudes

Social cultural factors

Social influence

Family members, health
care providers, and
friends

access to health
care services

Distance, cost, waiting
time, and gender of the
service provider.

Example
“The procedure of cervical cancer is painful” (Respondent
5).
“I have no information about it and how to prevent it.”
(Respondent 5).
“All women are equally at risk of having cervical cancer
not just HIV positive women.” (Respondent 7).
“… some husbands cannot stay without sex for one week”
(Respondents 11).
“It can give us double stress and burden as we already
have HIV that has no cure, the same with cancer. It is
better to stay without knowing that I have cancer as I am
already HIV positive” (Respondents 2,3).
“My daughter in-law told me that the procedure is not
painful and encouraged me to go for testing” (Respondent
1).
“… I have never heard from doctors talking about cervical
cancer….” (Respondent 5).
“The doctors told my friend not to have sex for one week
after the procedure. (Respondents 11).
“… although the screening services are free, we pay for
transport. It is better if doctors examine us as we are
starting ARV…to save transport money and time”
(Respondent 9).
“It took me the whole morning… and I returned back
home without being screened” (Respondent 9).
“I returned without screening as there was a male
provide”,

In Table 5, the study results indicated that some HIV-positive women had limited
knowledge regarding cervical cancer and screening services. In addition, women feared the
positive result as there is no treatment for cancer and it can be a double burden: that is having
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HIV and cervical cancer. This shows that women do not know that cervical cancer is a
preventable disease and can be treated if diagnosed at an early stage. The study results
indicated that there was need to examine the level of knowledge and attitude at an individual
level regarding cervical cancer and screening among HIV positive women in Malawi. The
results also indicated that women get information about cervical cancer and screening from
their social networks like health care providers, friends, and family members which influence
their decsion to undergo screening. This suggests the importance of further exploration of
social networks of women living with HIV-infection to develop a targeted intervention to
increase screening behavior to prevent cervical cancer. Further, the report indicated that
fragmentation of the HIV and cervical cancer services was a major barrier to cervical cancer
screening. Some women were not comfortable being examined by a male service provider
when they were not in labor. This indicates that the gender of the healthcare provider
performing the cervical cancer screening appeared to be a barrier to access screening services
for some of the participants. Refusing to be examined by men reflects cultural unacceptability
of reproductive health services like cervical cancer screening to be provided by male service
providers. Therefore, access to screening services needed to be explored further.
In conclusion, the pilot study findings clarified variables of interest and assisted in
formulating the Situation-Specific theory in the context of HIV positive women in Malawi,
literature review, and the design of the study to quantify the variables related to cervical
screening behavior.
Situation-Specific Theory. The Situation-Specific Theory (Refer to Figure 1)
concepts and methodological approaches consider the uniqueness of Malawian HIV positive
women in examining the screening rate and factors influencing cervical cancer screening.
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Figure 1. Situation-Specific Framework: Cervical Cancer Screening among HIV Positive
Women.

The concepts of the theory are cervical cancer screening, individual factors, social
support networks, and access to health care. The conceptual framework shows a
multidimensional nature of cervical cancer screening behavior. In the situation-specific
theory, the cervical cancer screening decision is conceptualized as more than just an
individually rational decision but also includes social influences and access to health care.
The demographic characteristics are unchangeable external factors that directly and indirectly
influence behavior towards cervical cancer screening.
Cervical cancer screening. This is the outcome variable of the study. Screening
involves checking the cervix for signs of cancer when there are no symptoms (Ferlay et al.,
2012). According to the framework, screening is measured by the woman‟s receipt of vaginal
examination by a health care provider (doctor, clinician or nurse) using a speculum to view
the cervix, clean it, and then apply acetic acid or take a smear from the cervix to detect early
signs of cancer. In this study, the woman‟s self-report of receiving screening was verified by
the review of women‟s health passport record of cervical cancer screening as the preliminary
study findings revealed that many women confuse digital vaginal examination with
screening. This gave reliable data regarding screening behavior as self-report on screening
status was verified by record review.
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Individual factors. This refers to the knowledge and attitudes that women living with
HIV infection have that influence cervical cancer screening behavior. Knowledge is a
necessary component of health behavior change, but on its own, it is not sufficient to bring
about cervical cancer screening behavior change without attitude change. Knowledge is
defined as information that individuals have that influence what they do in relation to a topic
under study (WHO, 2015). In this study, knowledge is defined as the awareness about
cervical cancer risk factors, signs and symptoms and screening to prevent cervical cancer.
Attitudes refer to abstract learned reaction or response in a certain way to certain
situations (WHO, 2015). Women have different attitudes regarding cervical cancer and
cervical cancer screening as influenced by their beliefs, perceptions, emotions, and
misconceptions. In this study, attitudes refers to social cultural factors that women living with
HIV infection hold such as beliefs, feelings, and fears that influence cervical cancer screening
behavior.
Social support network factors. The common definition of a social support network
encompasses all social networks and social support that the individual receives from three
different sources that include family, friends, and significant others (Malde et al., 2015;
Zimet et al., 1988). Support networks are important to women‟s well-being for decision
making about their health behavior. In this study, social support network refers to social
influence and social support that women living with HIV get from family members, friends,
and health care providers.
Family. A family is made up of parents, partners, children, uncles, aunts, cousins and
grandparents that provide support in time of need. They are related to one another by blood.
Culturally, Malawians believe in extended families for financial, emotional, and social
support.
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Friends. Friends are important to women‟s decision making about their health
behavior. Friends recommend and bring moral and financial support regarding screening.
Friends are a source of information for cervical cancer and influence screening behavior. It
includes friends, church members, neighbors, and HIV support group members if they
recommend
Health care providers. The social support that women living with HIV receive from
health care providers such as nurses, clinicians, and non-professional staff influences their
decision regarding cervical cancer screening behavior. Health care workers serve as a source
of information for cervical cancer and screening services as well as providing emotional
social support and cervical cancer screening services to HIV-positive women which is
valuable in fighting stigma and cervical cancer in the country.
Access to health care factors. Access refers to factors that facilitates or hinders
women to receive screening services that include affordability, availability, accessibility,
accommodation, and acceptability (WHO, 2002). In the framework, access refers to the
distance to screening sites, transport, waiting time, and gender and age of the service provider
in relation to the definition of access by WHO.


Affordability. It refers to the ability to pay for transport to go for cervical cancer
screening services when the woman wants to be screened, The health care services in
Malawi is free,



Availability. Refers to the geographic distance to travel to health care facility for
screening services



Accessibility. Refers to waiting time and previous experience with health care
providers in health facilities and screening sites
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Accommodation. Refers to the perception of adequacy of health care provider‟s
operation in terms of skills, supplies or drugs and individual women perceptions
regarding cervical cancer disease and commitment for preventive services.



Acceptability. Refers to women‟s comfort with health care provider‟s characteristics
and privacy at the screening sites.

The Situation-Specific theory concepts guided integrated literature review in the context
of HIV positive women in Malawi as described in Chapter 2.
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CHAPTER 2
LITERATURE REVIEW
This chapter provides an overview of the review of existing literature relevant to the
concepts of the Situation Specific Theory for Malawian women living with HIV infection
(Mtengezo & Lee, 2018). An integrative literature review was conducted following the
concepts identified from qualitative pilot study to assess the status of cervical cancer
screening behavior, knowledge level, attitudes and factors influencing cervical cancer
screening among HIV-infected women. The aim of the literature search was to review what
others have done before to build upon these works on cervical cancer screening among HIVinfected women.
Medline, Cumulative Index to Nursing and Allied Health Literature Complete,
PsycINFO, SocINDEX, and Google Scholar were searched. Search terms included “cervical
cancer screening,” “VIA,” “screening,” “Pap Smear.” “HIV-positive women,” “knowledge,”
“attitude,” “practices,” “developing countries,” “developed countries,” “Africa,” “SubSaharan Africa,” and “Malawi." Due to the scarcity of peer reviewed articles in Malawi, other
gray literature from Government reports were included. Findings were categorized within the
context of the concepts of the Situation Specific Theory feasible within Malawian context.
The search yielded twenty-six articles as depicted in the search strategy flow diagram
(Refer to Attachment B). After setting limits, twenty relevant studies were summarized in an
evidence-based table (Refer to Attachment C). Of the twenty studies, eight were conducted in
Malawi but not specifically on HIV-positive women. Four of the eight studies conducted in
Malawi were qualitative studies, two were document review studies, one was a quantitative
study, and another one was a mixed methods study. Twelve studies were conducted on HIVpositive women (Six in Sub-Saharan Africa and six in developed countries). Nine of the
twelve studies were conducted in Sub-Saharan Africa and developed countries, nine were
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quantitative studies, two were mixed methods studies, and one was a qualitative study. The
results of the search show limited evidence of well-designed studies that have been done with
HIV-positive women regarding their knowledge and attitude both in developing and
developed countries and none were found from Malawi.
All the concepts of the Situation Specific framework were used to guide the
classification of the concepts extracted from literature. The link of the concepts, middle-range
theory and the empirical (CTE) indicators are shown in the CTE structure (Attachment D).
The findings of the literature review are summarized within the Situation-Specific framework
concepts of Malawian HIV-positive women which include cervical cancer screening,
knowledge, attitudes, social networks, social support, and access to health care services.
Cervical Cancer Screening
Malawi adopted a single visit approach to cervical cancer screening “screen and treat”
using VIA and cryotherapy (Refer to Table 6) in 2004 (Malawi, MOH, 2015).
Table 6

VIA TEST

Step 1:
Step 2:
Step 3:
Step 4:
Step 5:
Step 6:

Provide counselling on VIA test and obtain consent.
Inspect and palpate the abdomen and external genitalia.
Perform a speculum exam to view the cervix clearly.
Apply a 3-5% acetic acid solution (vinegar) to the cervix.
Observe for cervical change(s) after at least 1 minute.
Discuss the results with the woman. If the results are positive and eligible for
cryotherapy, counsel and offer cryotherapy.

CRYOTHERAPY

VIA Test and Cryotherapy

Step 7:
Step 8:
Step 9:
Step 10:

Provide counsel on cryotherapy and obtain consent.
Perform a speculum exam to view the cervix again (repeat VIA if necessary)
Perform the double-freeze cryotherapy technique.
Provide post-treatment and follow-up instructions to the woman.

The process of VIA involves vaginal speculum examination, followed by visual
inspection of the cervix for one minute after cleaning with a 3-5% acetic acid solution which
can be ordinary table vinegar or iodine (MOH, 2015). The test shows changes in the
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epithelial cervix cells as white blotches if abnormal precancerous cells are present. Then the
provider either treats immediately with cryotherapy by freezing the lesions with liquid
nitrogen to destroy them or refers the patient for further treatment (MOH, 2015). Women
with grade 3 lesions and more serious lesions require further treatment to include surgery.
Cervical cancer screening using VIA and cryotherapy in “screen and treat” approach is
feasible in Malawi and other low resource countries (Refer to Table 6) for the steps.
According to Malawi, Ministry of Health guidelines, the VIA targets 30-45-year-old women
(Malawi, MOH, 2015). This is because the VIA depends on visualization of the squamocolumnar junction (Sankaranarayanan & Wesley, 2001; McIntoch et al., 2001). Further, it is
indicated that after menopause, the squamo-columnar junction usually recedes into the
endocervical canal and cannot be seen. In a few countries, including Malawi, a downshift in
age for invasive cervical cancer and age for screening with VIA has been observed due to
HIV co-infection among 15-49 year old women (Ferlay et al., 2012). Therefore, screening
has been done with VIA and positive rate and cancer suspects have been detected in women
aged 29 or less (Msyamboza et el., 2016). The VIA is practical and harmless, and effective in
reducing the cervical cancer burden (CDC, 2010).
Cervical cancer screening recommendations for women living with HIV are different
from screening guidelines for HIV-negative women (Refer to Figure 2).
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Figure 2. The VIA and Cryotherapy Protocol in Malawi
The HIV-positive women require more frequent screening as they have increased risk
of developing cervical cancer than HIV-negative women. In Malawi, the MOH recommends
rescreening HIV-infected women annually and HIV-negative women every three years after
the initial test (MOH, 2015). Precancerous conditions normally progress slowly into cervical
cancer, but with HIV-infection, it progresses faster. Therefore, frequent screening in HIVpositive women has the potential to identify abnormal conditions before such progression. A
single screening can reduce cervical cancer mortality among HIV-positive women (Atashili
et al., 2011; Maseko, Chirwa, & Muula, 2015). Regular screening has been shown to decrease
the probability of death from cervical cancer between 80 to 90% (Arbyn et al., 2018;
Mandelblatt et al., 2002; Sasien, Adams, & Cuzick, 2003).
Several studies were found that evaluated the cervical cancer screening rate among
HIV-positive women in developing and developed countries (DalMaso et al., 2010; Ezechi,
Gab-Okafor, Ostergrem & Odbery, 2013; Maree & Moitse, 2014; Matangaidze,
Ramalivhana, Mbambo-Kekana, Ndaimani, & Mhlanga, 2016; Msyamboza et al, 2016;
Rosser, Njoroge, & Huchko, 2015; Sichanh et al., 2014). It is evident from these studies that
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there is variation in the prevalence of cervical cancer screening rate among HIV positive
women in developed and developing countries (Refer to Table 7).
Table 7
Prevalence of screening rate among HIV+ women
Author
Msyamboza et al., 2016
Low-resource countries
Ezechi et al., 2013; Maree & Moitse, 2014;
Matangaidze, et al., 2016; Rosser et al., 2015;
Sichanh, et al., 2014
Developed countries
Dal Maso, et al., 2010; Wigfall et al., 2013

Country
Malawi

Screening Rate
15.9%

Nigeria, South Africa,
Zimbabwe, Kenya, and Lao
PDR

3.9 – 84.0 %

Italy, USA

83.0 - 90.9%

In resource-limited countries, including Malawi, few HIV-positive women, as low as
3.9% in Nigeria, undergo cervical cancer screening although they are at increased risk of
developing cervical cancer (Sichanh et al., 2014). However, evidence has also shown that if
there are targeted interventions for HIV-positive women, the screening rate increases (Rosser
et al., 2015). For example, in Kenya, the Family AIDS Care and Education Services and HIV
program piloted the cervical cancer screening and prevention program at one HIV clinic. The
program provided free screening services to all women residing in the study area. This
program recruited HIV-positive women to assess cervical cancer knowledge, personal risks,
and screening behavior. The program evaluation found that 84% of HIV- positive women
underwent cervical cancer screening (Rosser et al., 2015). Some studies conducted in the US
and Italy also indicated a high screening rate for women living with HIV infection. For
example, the study in Italy evaluated the history of Pap smear in HIV- positive women in
relation to the socio-demographic and organizational factors associated with adherence to
cervical cancer screening (DalMaso et al., 2010). The study found that 90.9% of HIVpositive women had an initial Pap smear but only 66% underwent all the recommended Pap
smear follow-up tests.
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Evidence from literature revealed that screening was measured by a woman‟s selfreport of receipt of cervical cancer screening by either VIA or Pap smear approach (DalMaso
et al., 2010; Ezechi et al., 2013; Maree & Moitse, 2014; Matangaidze et al., 2016;
Msyamboza et al, 2015; Rosser et al., 2015; Sichanh et al., 2014). The women were asked a
single question: if they had ever been screened. Self-report is a method of collecting
information about an individual‟s health status and utilization of health care services.
Evidence has shown that self-reports may be used when medical records are unavailable
particularly for shorter recall periods (Short et al., 2009). Self-reports tend to give higher
rates than medical record review. The factors affecting accuracy of self-report information
may include education and health status (Short et al., 2009). Healthier women with higher
education are more likely to report accurate information than less healthywomen with low
education. Women living with HIV infection may be either sick or healthy but screening is
critical for all HIV-positive women. Therefore, factors influencing cervical cancer screening
were also reviewed in the literature. The results from the literature have been classified based
on the situation-specific concepts: individual factors, social support networks, and access to
health care (Mtengezo & Lee, 2018).
Individual Factors
In the pilot study, individual factors are operationalized as the understanding that
HIV-positive women have about cervical cancer and screening and how it influences their
screening behavior (Mtengezo & Lee, 2018). Several qualitative studies were conducted in
Malawi about cervical cancer screening, but were not specifically with women living with
HIV infection (Chadza et al., 2012; Maseko et al., 2015; Fort, Makin, Siegler, Ault, &
Rochat, 2011). Most of these studies explored individual factors contributing to delay in
seeking cervical cancer services in Malawi. The major theme found was that women had
limited knowledge regarding cervical cancer and screening. Further, the literature indicated
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that women had heard about cervical cancer but did not know what the disease was all about
(Ports, Reddy, & Rameshbabu, 2013). A mixed methods study was conducted to assess client
satisfaction after undergoing screening and this study found that satisfaction was predicted
by having previous knowledge of the VIA test with 98% of these women reporting
knowledge of the disease seriousness as their motivation for getting screened to know their
status (Maseko, Chirwa, & Mvula, 2014). However, the majority (80%) had limited
knowledge about how the disease was caused, and 71.8% had no idea of how the VIA
screening test was done. Further, the study revealed that young women thought that they
might not have children after undergoing VIA as the procedure burns the womb (Ports et al.,
2013). Another document review study was conducted to identify barriers to utilization of
cervical cancer screening in low and middle-income countries including Peru, Mexico, South
Africa, Kenya and Malawi (Maseko et al., 2015). The study found that lack of awareness and
knowledge about risks and prevention of cervical cancer were related to age and marital
status of participants. Married women had a higher recognition of cervical cancer risk factors
than those who had never been married. Also, women who were older and had higher income
or heard of cervical cancer were more likely to utilize prevention services than young women
with little income. Since there are no studies conducted in Malawi to understand HIVposivtive women‟s knowledge related to cervical cancer screening, a review of published
studies extended to other developing and developed countries.
The published studies conducted in South Africa, Zimbabwe, Kenya, Nigeria, US, and
Lao PDR in Asia on HIV-infected women‟s cervical cancer-screening knowledge indicated
conflicting results. Some studies indicated that women had inadequate knowledge about
cervical cancer screening although they all were at risk for cervical cancer (Matangaidze et
al., 2016; Wake et al., 2009; Sichnh et al., 2014). Women reported that they did not undergo
screening because of lack of knowledge about the examination (Matangaidze et al., 2016;
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Wake, Rebe, & Burch, 2009). The results of these studies suggest that knowledge is
associated with screening and is an important factor for behavior change; for example,
women who had heard of cervical cancer and screening, also had a higher screening rate
(Rosser, et al., 2015; Wigfall, et al., 2015). Interestingly, some studies, found that women had
knowledge about cervical cancer (78.7%) and screening (62.9%), but for being screened, the
rate was still as low as 22.3% (Maree & Moitse, 2014). If women have knowledge about
cancer and screening, why is the screening rate low? Do they have the correct information?
Other studies indicated that some women had heard of cervical cancer and screening but had
inadequate knowledge of screening usefulness (Sichanch, 2014; Wake, et al., 2009). In
addition, most studies conducted in Sub-Saharan Africa, did not use instruments that were
culturally sensitive within their setting as they used instruments that were validated in
developed countries like the USA for all women and not HIV-positive women. Some
components of knowledge between the link of HPV and HIV were missing. The finding
could mean that knowledge in previous studies was not measured accurately leading to
conflicting results or that knowledge is not the only factor that influences their screening
behaviors. For women to make informed decisions about cervical cancer screening, they need
to have the correct knowledge about cervical cancer and screening. Limited knowledge
contributes to delay in seeking cervical cancer screening and treatment services. No study in
Malawi was found that measured the level of knowledge regarding cervical cancer screening
in HIV-positive women. The study that was conducted regarding knowledge was the MDHS
(2017) report that shows that knowledge about diseases such as HIV/AIDS increases with
higher education level attainment. Educated people are more likely to access health care
services compared to those with little or no education. Education and knowledge about
diseases is therefore an important determinant of health to consider in behavioral studies.
Therefore, knowledge regarding cervical cancer and screening in HIV- positive women needs
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to be further explored given their increased risk of developing cervical cancer. Knowledge is
a necessary component of health behavior change, but on its own, it is not sufficient to bring
about cervical cancer screening behavior change without an attitude change at an individual
level.
Women have different attitudes regarding cervical cancer screening. Various studies
have been conducted to evaluate HIV-positive women‟s attitudes regarding cervical cancer
and screening in different countries using different instruments (Ezechi et al., 2013; Maree &
Moitse, 2014; Matangaidze et al, 2016; Bynum et al., 2013). In Malawi, only a few
qualitative studies were found in the literature on attitudes regarding cervical cancer
screening (Chidyaonga-Maseko, Chirwa, & Muula, 2015; Fort et al., 2011; Munthali,
Ngwira, & Taulo, 2015). In qualitative studies on perceptions of cervical cancer screening
among women in Malawi, it was found that women had misconceptions about the VIA
procedure which prevented some women from going for the service (Chidyaonga-Maseko et
al., 2015; Munthali et al., 2015; Ports et al., 2013). Women had misperceptions that the VIA
procedure causes cancer as health workers use acid during the process which burns the
cervix. Some studies revealed that women felt that it was not appropriate to discuss
reproductive health issues with young women (Chidyaonga-Maseko et al., 2015). Some
women when they are healthy think they do not need any preventive interventions like
exposure to the VIA process and visit the hospital only when they are sick (Munthali et al.,
2015). Consequently, they delay in seeking care services including cervical cancer screening.
In cross-sectional studies conducted in South Africa and Kenya to determine the knowledge
level of women regarding cervical cancer and screening, it was found that most did not
undergo screening as they feared the procedure because they had heard that it was painful
(Maree & Moitse, 2014; Rosser et al., 2015; Sichnh et al., 2014). These study results indicate
that many women have incorrect information about screening which may have led to
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increased risk of developing cervical cancer because low levels of knowledge and negative
attitudes contribute to low screening behavior. However, studies conducted in Nigeria,
Zimbabwe, US and South Africa indicated that 77.4 -84.9% of women had intentions of
undergoing screening in the future (Ezechi et al., 2013; Matangaidze, et al., 2016; Wake et
al., 2009). Based on women‟s intentions to undergo screening in the future, these studies
conclude that most women have positive attitudes regarding cervical cancer screening, as
they perceive cancer as a dangerous disease. Intentions do not mean that women will undergo
screening. No study has been conducted to measure the beliefs, feelings, and fears of HIVpositive women regarding cervical cancer and screening in Malawi. There is need to establish
whether attitude at an individual level influences screening behavior among Malawian HIVpositive women.
Social Support Networks
Social support networks have various definitions in the literature. Social support
consists of social relationships that can provide material, emotional, informational and
instrumental resources (Kadushin, 2011; Malde et al., 2015; Mtengezo & Lee, 2018; Zimet,
Dahlem, Zimet, & Farley, 1988). Various studies investigated the relationship between social
support and depression in pregnant or postpartum mothers and they have shown that social
support networks influence various behavior changes (Lubben et al., 2006; Stewart, Umar,
Tomenson, & Creed, 2014; Nakigudde, Musisi, Ehnvall, Airaksinen, & Agren, 2009). This
literature review found limited studies conducted on the relationship between social influence
and screening behavior among HIV-positive women in developing and developed countries
(Ezechi et al., 2013; Maree & Moitse, 2014; Wigfall et al., 2015). The social influence was
also related to social cultural factors that influence cervical cancer screening (Williams,
Moneyham, Kempt, Chamot, & Scarinci, 2015). In a pilot study, it was found that social
networks include spouse, parent, child, in-laws, relatives, friend, church members, neighbors,
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health care providers, and HIV support group members. Social support network has
multidimensional constructs and is influenced by family members, friends, and health care
providers (Mtengezo & Lee, 2018).
Family. From the literature, no study was found that examined family as a social
influence for cervical cancer screening behavior. In other behavior studies, like HIV/AIDS,
family and social support networks play an important role in stigma after HIV diagnosis and
in the utilization of preventive health care services (Malawi Network of People Living with
HIV and AIDS [MANET+], 2012). Both cervical cancer and HIV/AIDs are sexually
transmitted diseases and both are linked to having multiple sexual partners. Therefore, there
is stigma within the family and this remains the largest barrier to individual and public action
to preventive services. This may suggest that when HIV-positive women go for screening
services, they are indirectly disclosing that they have multiple sexual partners and may be
stigmatized by family members. This may suggest the importance of studying the role of
family members in preventive services.
Other studies have also shown that people living with HIV/AIDS (PLHA), have
actual or imagined fear or worry of negative societal attitudes and possible discrimination
was arising from having HIV an infection (Kamen et al., 2015; MANET+, 2012; Neuman &
Obermeyer, 2013). Fear or self-stigma included both the concern of exposure to
stigmatization and the potential internalization of the unfavorable beliefs and feelings related
to the stigmatized HIV condition (Rueda et al., 2012). The PLHA know how their social
networks including families stigmatize them, and they react by accepting society's negative
judgment of their identity as an HIV-positive person and that they will die. The amount of
stigma PLHA already have experienced from the societal networks, read about or heard of,
affects their decisions and future actions in preventive services. There are variations in
reactions as some PLHA self-blame for the HIV positive status while others feel they got the
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HIV infection because of their partners' infidelity and blame their partners (Neuman &
Obermeyer, 2013). The PLHA also have negative decisions about HIV care, treatment,
support and preventive services. Decisions that HIV-positive women make include not taking
medication, and missing hospital appointments (Bedell, Van-Lettow, & Landes, 2014). When
women miss their medication, they compromise their immune system and may risk higher
rates of human papilloma infection, and some other types of cancers (WHO, 2010). Providing
preventive health services is critical in HIV-positive women to prevent cancer. The
preventive services may include breast, colorectal and cervical screening, and sexually
transmitted infections testing, and counseling on sexual behaviors (WHO, 2010).
Understanding information flow within a network can serve as a useful tool in predicting the
most influential social networks that can be targeted for information, education, and
communicating cervical cancer preventive messages. The pilot qualitative study revealed that
HIV-positive women seek information regarding cervical cancer from families, friends, and
health care providers.
Friends. A study was conducted in the US to examine associations between women
living with HIV/AIDS, cervical cancer prevention knowledge and abnormal Pap test history
(Wigfall et al., 2015). The authors found that women who had members of their social
network who had an abnormal Pap test history knew about cervical cancer screening and
follow-up care for a woman who is HIV-positive and the screening rate for these women was
83% (Wigfall et al., 2015). The results of the study may suggest that friends offer advice,
direction, and information that influence their social networks to adapt behavior change
interventions. On the other hand, the results could mean that friends rely on each other and
share joys, sorrows or problems and influence each other.
Health care providers. Various studies have shown that health care providers are
important when it comes to decision making about health behavior (Maree & Moitse, 2014;
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Ezechi et al., 2013). In a study conducted in South Africa to determine what women treated
with HIV/AIDS knew about cervical cancer and screening found nurses and doctors as the
most likely sources of information (Maree & Moitse, 2014). The study conducted in Nigeria
to assess the willingness and acceptability of cervical cancer screening among HIV-positive
women found that religious denial (14.0%) was the most common reason given for refusal to
take the test (Ezechi et al., 2013). The studies may indicate that health care providers are
sources of information to influence cervical cancer screening behavior.
Access to Health Care Services
The success of any prevention program is linked with the quality and accessibility of
health services. In literature, the dimensions of access include barriers and facilitators
relating to cervical cancer screening such as affordability, availability, accessibility,
accommodation, and acceptability (Maseko et al., 2015; Maseko et al., 2014; Munthali et al.,
2015; WHO, 2002).
Accessibility. In literature, accessibility refers to barriers and facilitators regarding
access to screening services but not specifically on HIV-positive women (Maseko et al.,
2015; Maseko et al., 2014; Munthali et al., 2015). The results of the studies in the literature
indicated that the accessibility of health care services is linked to previous experience with
resources, service providers, and waiting time (Maseko et al., 2015; Maseko et al., 2014;
Munthali et al., 2015). The study results have indicated that women can access preventive
health care services if the waiting time to receive the service is short time and if they are
treated with respect by the service providers. There must be more screening sites and trained
health care providers to provide the screening services for the women not to wait for a long
time. A recent study conducted on cervical cancer screening behavior and challenges in
Malawi found that the screening sites increased from 75 to 130 from 2011 to 2015 and are
free and available in most district public health facilities but women still wait for a long time
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to be screened such that some to go back home without being screened (Msyamboza et al.,
2016). Even though the screening sites have been increased, they are still too few as the
estimated total number of health facilities in Malawi is over 500. When creating demand by
advocating for screening services, the health facilities must be able to supply the demand by
training more service providers and opening more screening sites would reduce waiting time.
Accommodation. Accommodation refers to the perception of adequacy of provider‟s
operation in terms of skills and supplies or drugs (WHO, 2002). In a study conducted on
health workers‟ perceptions about health system challenges in implementing cervical cancer
screening services in Malawi, health workers reported that lack of supplies like vinegar and
space made it inconvenient for women to go for screening (Maseko et al., 2015; Munthali et
al., 2015). Further, it was reported that in some health facilities, there was inadequate space,
and they alternate services or provide the service only once a week or women wait until other
people finish other procedures to start providing cervical cancer services. Few members of
staff were trained and committed to the provision of cervical cancer screening and early
treatment services (Maseko et al., 2014; Munthali et al., 2015). In another study, it was
reported that women made several hospital visits to seek care despite their limited resources;
unfortunately, drugs were sometimes prescribed without proper assessments (Chadza et al.,
2012).
Acceptability. Acceptability refers to privacy and comfortability with the health care
provider (WHO, 2002). A qualitative study conducted in Malawi, found that using male
service providers hindered the use of screening services because women did not want male
providers to see their private parts except when they were in labor (Munthali et al., 2015).
Some husbands and certain cultures do not want women‟s private parts exposed to a male
service provider when not in labor. The use of male service provision in preventive health
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services is multidimensional concept and may present a barrier that needs to be explored
among HIV positive women.
Availability. Availability refers to distance to screening sites (WHO, 2002). Long
distance to the health facilities is also a major barrier for women to access cervical cancer
screening services. In three qualitative studies the participants stated that the hospital where
they provided screening services were too far (Chadza et al., 2012; Lee, Makin, & Mtengezo,
2015; Ports et al., 2013),. Ports and colleagues (2013) reported that the average time to walk
to the nearest clinic was 45 minutes. Maseko and colleagues (2014) found that participants
covered a distance between one and five kilometers to reach the screening centers. Maseko
and colleagues (2015) found that only 33.3% (7/21) of the health facilities provided both
screening and cervical cancer treatment services. Cervical cancer services were offered at
primary, secondary and tertiary level. At tertiary level, the access of health care is often
misunderstood and confusing in the country especially in the districts that offer all three
levels of care like Lilongwe. There is a policy that women must visit the health center for
primary care and the health care providers must refer an individual to a district hospital for
secondary care and the district must refer to a central hospital for tertiary care. Even if a
woman lives close to district hospital or central hospital, she cannot access health care there
directly. Even though the district is in an urban area, some health clinics are far from the
district and central hospital. Therefore, women may visit the clinics when the disease is at an
advanced stage (Chadza et al., 2012; Lee et al., 2015; Ports et al., 2013).
Affordability. Affordability refers to the ability to pay for cervical cancer screening
services (WHO, 2002). In Malawi, public health services are free. Maseko and colleagues
(2015) reported that there are no user fees to access cervical cancer screening and treatment
in public health facilities; however, women are required to purchase health passports if they
do not have one, which may be a barrier to receiving cervical cancer screening. Christian
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Health Association of Malawi (CHAM) facilities charge a consultation fee. The CHAM
health services are available in urban and rural areas and provide 85% of health care in the
rural areas. These CHAM health facilities are close to where the women live, but because
they charge the consultation fee, few women access care at CHAM facilities. Even if the
consultation fee is minimal, women travel a long distance to access free services in a public
hospital even though the use of public transportation might be more than the consultation fee
even though in an urban area. When women do not have money to pay for the medical
services at private hospitals or transport to the free government hospitals, they just stay at
home and visit the health facility when cancer is in the advanced stage. Studies conducted in
Kenya and Nigeria found that women pay for cervical cancer screening services and the costs
varied from country to country (Ezech et al., 2013; Rosser et al., 2015). However, even in
some developing countries like Malawi, where there are no user fees, and HIV-positive
women access the ART clinics for their treatment monthly or every three months, the
screening rate for HIV-positive women is very low (15.9%). The findings indicate that there
are policy and systematic challenges to cervical cancer screening like resources, gender of
provider, availability of service providers and time taken to access screening services. Most
studies have focused on physical and economic access to health care. However, a more
evidence-based definition of access to care is missing that links the success of any preventive
disease efforts directly with the quality and accessibility of the services. Therefore, it is
important to assess HIV-positive women's dimensions of health care access and how they
may influence cervical cancer screening behavior while considering their socio-cultural
factors.

33

Summary of Literature Review
The literature review findings demonstrated that the prevalence of cervical cancer
screening rate among HIV positive women mostly were by women‟s self-report of the receipt
of screening. In this study, the woman‟s self-report of receiving screening was verified by
record review. This gave reliable baseline data regarding screening rate among HIV positive
women in Lilongwe, Malawi. Limited studies in both developed and developing countries
have shown that women with low levels of knowledge and negative attitude regarding
screening are unlikely to access screening services. There are also limited empirical studies in
the literature regarding the correlates of cervical cancer screening among women living with
HIV infection for hypothesis testing. There was also no instrument to measure the situation
specific concepts in the context of Malawian women living with HIV infection. If there are
no standardized instrument to measure specific variables of interest, evidence has indicated
that qualitative studies inform the development of a quantitative tailored instrument (Lee et
al., 2015). Therefore, the literature review findings and preliminary qualitative study results
assisted in developing a culturally sensitive instrument to inform a cross-sectional
correlational study design for this study. The detailed methodology of the study and
instrument development is outlined in research methodology, chapter 3.
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CHAPTER 3
RESEARCH DESIGN AND METHODS
This chapter describes the research methodology used for this study. It highlights the
study design, study population, setting, sampling method, data collection procedures, and
data statistical analysis.
Design
The study used a cross-sectional health survey design to examine the prevalence of
cervical cancer screening, level of knowledge and attitudes regarding cervical cancer and to
determine factors (individual factors, social support networks, and access to health care)
related to cervical cancer screening behavior.
Study Setting
The study was conducted in both rural and urban HIV support groups in Lilongwe,
Malawi. Lilongwe is a district in the central region of Malawi. The district covers an area of
6,159 square kilometers and has a population of 1,346,360. The district is the capital city of
Malawi and is considered an urban district. Despite being an urban district, the district has
diverse levels of people with different socio-economic status in urban and rural settings. The
district covers all three levels of the health care delivery system within the city including the
primary, district, and tertiary levels giving a good representation of the target population
across the district. In addition, the HIV prevalence is two times higher in urban areas than in
rural areas, 17.4% versus 8.9% (MDHS, 2017). The district HIV prevalence rate is 9.2% and
has many HIV support group dealing with people living with HIV/AIDS (UNAIDS, 2014).
Most HIV support groups were established to support people living with HIV/AIDS to live a
quality productive life. They are membership organizations and the members are in all
districts of Malawi. For example, the National Association of People Living with HIV/AIDS
in Malawi (NAPHAM) was establised in 1993 by a small group of PLHIV who observed that

35

their needs were not being met. The organization fights stigma and discrimination, advocates
for supportive environments for PLHIV, and facilitates localized support groups for those
who are infected and affected by HIV and AIDS. Another organization is the Coalition of
Women Living with HIV/AIDS (COWLHA) and it unites different groups of women as a
civil society force in dealing with issues on gender and women‟s rights in the context of HIV
and AIDS that impact the lives of women living with HIV and AIDS in Malawi.
Study Population
The study targeted Malawian HIV-positive women in support groups in Lilongwe
District. The inclusion criteria was: HIV positive women in HIV support groups aged 18 and
above with a cervix, active members of HIV support organizations, willing to participate in
the study, and able to speak Chichewa or English. The inclusion criteria included women
aged 18 and above as Malawi‟s HIV prevalence is highest among women aged 15-49 years
(12.9%). The HPV infection occurs shortly after the onset of sexual debut. Evidence has
indicated that 35% of the women are infected within 2 years of initiating sexual activity
(Collins et al., 2002; Kjaer et al., 2001). In addition, the screening data has revealed that VIA
positives and cancer suspects were detected in 2.3% in women aged 29 or less, and 1.2% in
women over 45 years (Msyamboza et al., 2016). This is a large population in a high
prevalence rate country for cervical cancer and HIV. The exclusion criteria included women
who had a total hysterectomy, women with known allergy to acetic acid, and women who had
cervical cancer screening before HIV diagnosis.
Sampling Method
Sampling frame: The sampling frame was the HIV Support group registry at the
Lilongwe District Aids Coordinating Office that was used to identify all HIV support groups
in Lilongwe District. There are six HIV membership support organizations in Lilongwe that
support Malawian women living with HIV/AIDs. There are eighty-four support groups, and
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the membership varies between 20-100 in each support group. In total, there are over 4,200
HIV-positive women and men in Lilongwe District and among these members, 3,360 (80%)
are women aged 18 and above.
Sample size: The outcome variable was cervical cancer screening which was
measured by the receipt of cervical cancer screening after HIV diagnosis. The sample size
calculation was estimated by using G-power and sample size calculator based on the
prevalence of the outcome variable of interest (Rosner, 2011). In Malawi, the cervical cancer
screening coverage for HIV positive women is 15.9% (Msyamboza et al, 2016). Using 15.9%
as the maximum expected prevalence of cervical cancer screening rate among HIV-positive
women, a margin of error equal to 0.05 in 95% confidence interval, a minimum sample size
of 206 participants was needed to be selected from a population of 3,360 HIV positive
women in support groups in Lilongwe District.

Z 2 a / 2 * P * (1  P) 1.962 2 * 0.159 * (1  0.159)

 206
Formula : n 
D2
0.05 2
•

The margin of error: 0.05 (5%) =Chance to tolerate wrong conclusion

•

The CI: 95%

•

Population (3,360) : use infinite 100,000 since the actual size is not known- drop and
join

•

Prevalence of screening rate in HIV Positive women: 15.9% (previous studies)

•

Z= Standard normal variate = 1.96 at 5% type 1 error

•

D = Absolute error of precision
Considering that 70% would agree to participate in the study and 10% missing data,

291 women meeting the criteria in the selected HIV support groups were invited to
participate in the study.
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Sampling: Two staged proportionate stratified cluster random sampling method was
used to select subjects proprtionally to the population size of HIV positive women in urban
and rural geographical areas and by agegroup (Refer to Figure 3).
4200 HIV positive men and
women (84 support groups)

Exclude Men, women
under 18, those with total
hysterectomy and allergic
to acetic acid

3360 HIV positive women,
>18 (84 HIV support groups)

Stage 1
Urban (60%): N= 2016

Rural (40%): N= 1344

175 (Cluster random sampling: 10 support
groups)

116 (Cluster random sampling: 5 support
groups)

Stage 2
40% Age-group 1829
70

60% Age-group >30
105

40% Age-group 18-29
46

60% Age-group >30
70

291 Invited and completed the study

Figure 3. Two Stage Proportionate Stratified Cluster Random Sampling

In proportionate stratified sampling, the examined population is divided into distinct
subgroups, called strata and a predefined percentage of participants are selected in each
stratum (Levin & Kanza, 2014). The population of interest was HIV positive women
attending HIV support groups in Lilongwe District which was approximately 3,360 women.
The population was stratified by geographic location: Urban and Rural of Lilongwe District
(Refer to Figure 4).
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Figure 4. Urban and Rural Area of Lilongwe District.
and by age-group. The age group was divided into two groups: 18-29 and 30 and above in
each stratum. The HIV positive women were identified through a register obtained from
Lilongwe District Health Office in the capital of Malawi. The sample size was calculated by
using a percentatge of the proportionate of each stratum. For example 60% of the participants
were of the age-group between 39-50 and 40% age group 18-29 to ensure that the number of
selected subjects for the sample from each age-group was proportionate. The same was done
for geographical allocation. The sample size (291) was multiplied by 60% (291*0.6 = 175)
for Urban and by 40% (291*0.4 = 116) for Rural. Simple random sampling was used to select
10 support groups as clusters in 4 Traditional Authorities in urban area and 5 support groups
in 3 traditional authorities in rural area. Simple random sampling was done by writing all the
names of the HIV support groups on a small paper and putting them in a ballot box; the
proportinate of the support groups were selected by picking papers randomly from the ballot
box. All women meeting the criteria, in the randomly selected support groups were invited to
participate in the study until the sample size was reached. Stratified random sampling reduces
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potential for human bias in the selection of subjects to be included in the sample and provides
the sample that is highly representative of the popultation being studied.
Measurement
The questionnaire for this study was purpose-designed based on the specific needs of
this study within the Malawian context. The instrument development process followed the six
stages as stipulated by Lee and colleagues (2015) which include: conducting literature
review; conducting qualitative study; selecting items; translating; conducting cognitive
interviews; and conducting the full-scale survey (Lee et al., 2015).
The questionnaire was developed basing on literature review (Mtengezo & Lee, 2018;
UCL, 2011; WHO, 2002; WHO, 2008; Zimet et al., 1988) with modifications in line with
research questions and qualitative study findings to fit the local context of Malawian women
living with HIV infection. The qualitative study was conducted by the researcher to learn
how women living with HIV in Malawi conceptualize and describe cervical cancer screening
to have a culturally relevant tool by using the language that women living with HIV
understand. Items for the survey were selected based on the situation specific conceptual
framework concepts and middle range theories from the literature review. The terms used in
the survey were based on the language women use in Malawi. For example, the term
“screening” to local Malawians is called “examination” so women were asked if they had
been “examined for cervical cancer”. In addition, cervical cancer in the local language is
called „Khansa la khomo lachiberekero”. After development, the instrument was given to
committee members and cervical cancer clinical experts to conform to content and face validity
of the developed instrument.
Translation of the instrument. In Malawi, about 75% of women and 83% of men
are literate (MDHS, 2017). In addition, 12% of women aged 15-49 have no education and 6
in 10 women have only attended primary education and are not fluent in English. Therefore,
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the developed English instrument was translated into the local language, Chichewa, so that
the questionnaire was easily understood by the women. The WHO recommends an approach
that makes use of forward and back translations, input from experts, and pretesting with
target populations to ensure that the translated instrument valid and reliable (WHO, n.d).
During forward translation, two independent translators who were bilingual experts and
familiar with the study content, and everyday language, culture, and health of Malawians
translated the developed instrument into Chichewa then it was back translated into English.
The two versions were compared for conceptual equivalence and synthesized. However,
during the translation process, the translators could make their own assumptions as to what
was and was not important, and they might have missed something that was important.
Therefore, the tool was tested by conducting cognitive interviews to refine the study
questionnaire.
Pre-testing the instrument. Cognitive interviews were done by conducting focus
group interviews with five HIV positive women. Cognitive interviewing is a popular method
for obtaining construct validity on the survey questions to check for factual information,
wording, clarity, ambiguity in the translated questionnaire, and to ensure that the respondents
interpreted the items in the manner intended (Lee et al., 2015; Willis & Artino, 2013). During
interviews, women were asked to think-aloud what certain terms meant and were requested to
rephrase the questions in their own words. Participants were asked about the terms that were
not clear and if there were alternative terms that they preferred. The responses were used to
assess understanding and cultural appropriateness of the questionnaire for adaptation. The
survey tool was adjusted accordingly, and the researcher made corrections to the instrument.
The changes in the questionnaire were on the attitude scale, when 1 item “afraid of
discomfort” was merged with “afraid of pain” as women expressed that according to their
understanding, pain and discomfort meant the same. Therefore, the final version for the
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attitude scale had six items and not seven. Also, on the access scale, 2 questions were deleted.
One question on affordability “no money for service fee” as women indicated that the
services are free in Malawi and the question was not applicable. The other question that was
deleted was on acceptability “I do not want people that I know to see me”. Women indicated
that being HIV positive and on drugs means they already visit the clinic. The results from the
pre-test also helped to check the internal and external validity of the questionnaire. Therefore,
the final instrument had 83 items and covered the following 6 major domains of the study
(Refer to Table 8): Demographic characteristics with 8 items, cervical cancer screening
behavior with 5 items, knowledge with 31 items, attitudes with 6 items, social support
networks with 11 items, and access to health care with 12 items. Internal consistency of the
instrument was assessed using cronbach alpha.
Table 8
Study Concepts, Variables and Measures
Concepts
Demographic
characteristics

Variables
Education

Religion
Occupation
Income
Age
Marital Status
Time of HIV Diagnosis
Number of pregnancies
Cervical cancer
screening

Cervical cancer screening

Screening method
Time when screened

Definition
1 = never attended or
primary level
2 = secondary/
university level
1= Christian
2= Others
1 = not working
2 = working
1 = <$100
2 = < $100
Age in years
0= single
1= married
Year of diagnosis
Number

Measures
Scale
Ordinal

Nominal
Nominal
Ordinal
Interval
Nominal
Interval
Interval

0= never had
Nominal
screening
1= ever had screening
1= VIA
Nominal
2= Pap smear
1= Before HIV
Nominal
diagnosis
0= After HIV
diagnosis
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Instrument
Developed

World Health
Survey (WHS)
(WHO, 2002)

Screening frequency

Individual factors

1= every year
0= not every year
Year of last screened

Time of last screened
Knowledge 31 items
Risk factors (13 items)
Signs and symptoms (11
items)
Prevention (3 items)
Awareness (4)- Translated

Social support
network

Access to health
care services

The sum of 4
subscales

Attitude 5 items
Fear:
-procedure
-pain,
-discomfort,
-bleeding,
-diagnosis
11 items with 3 subscales
Family: Tries to help,
emotional support, talk
about my problem, and
willing to help
Friends: Try to help, count
on friends, share my
problem, and talk about my
problem
Significant others: special
person around me, share
my problems, real source of
comfort and cares about me
12 items ( 8 translated)
with 5 subscales
Affordability: cost and
transport, able to get the
services
Availability: service
providers and facilities
Accessibility: Travel time
and travel mode
Accommodation: Provider
skills, equipment, and
engagements
Acceptability: Providers
gender and privacy
Acceptability

The sum of 5 items

The sum of 3
subscales

The sum of 5
subscales

Nominal
Interval

Nominal

Nominal

Nominal

Nominal

Cervical Cancer
Awareness
Measure
(Cervical CAM)
(UCL, 2011).
Cronbach‟s
alpha – 0.70
- (KAP Survey)
(WHO, 2008)
Cronbach‟s
alpha – 0.79 0.84 validated in
Zimbabwe
Multidimension
al Scale of
Perceived Social
Support
(MSPSS) Scale
(Zimet et al.,
1988).
Cronbach‟s
alpha .83 to .93

World Health
Survey (WHS)
(WHO, 2002).
-Cronbach‟s
alpha -not
indicated but it
is used in
studies in
Malawi.

Table 8 describes the major study concepts, variables and measures of the
instrument. The primary outcome of the study was cervical cancer screening after HIV
diagnosis. The independent variables are socio-demographic, knowledge, attitude, social
support network, and access to health care support. The operational definitions of variables
are as follows:
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Socio-demographics. The socio-demographic characteristics of the respondents were
obtained to have a sociodemographic background of the study sample. Additionally, the
demographic characteristics variables have been empirically reported to influence bahavior in
health issues. There were 8 questions on socio-demographic details of HIV-positive women
which include age, marital status, education level, occupation, income, religion, number of
pregnancies, and when they were diagnosed with HIV. For marital status, the respondents
reported their marital status and included single, married, divorced or widowed. In age
category, the respondents report their age in years at their last birthdate. In education level,
the respondents reported their highest education attainment. For occupation, the respondents
reported their occupation in terms of current employment status. For income, the women
reported their monthly income status. For duration of having HIV disease, the respondents
reported the year they were diagnosed HIV positive. The respondents also reported the
number of pregnancies they had ever had.
Cervical Cancer Screening. The primary outcome of the study was cervical cancer
screening which was obtained from two sources: self-report and medical record check of the
receipt of vaginal examination from a cervical cancer health care provider after HIV
diagnosis. The participants were asked if they had ever had a vaginal examination using a
speculum to examine the cervix or if a pap smear was taken. In this study, self-report was
verified by the review of women‟s health passport record of cervical cancer screening as
some women are not able to differentiate digital vaginal examination and screening.
Triangulating self-report and record review gives reliable baseline data regarding screening
rate among women living with HIV infection in Malawi. If the women had ever been
screened, there were follow-up questions: If the screening method was either by VIA or Pap
smear or both. Then the woman was asked if the screening was done before HIV diagnosis or
after HIV diagnosis.
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Individual Factors. The individual factors were assessed in terms of participant‟s
knowledge and attitude regarding cervical cancer and screening.
Knowledge. The knowledge about cervical cancer and screening was measured using
Cervical Cancer Awareness Measure (Cervical CAM) Toolkit Version 2.1 (UCL, 2011) The
Cervical CAM has 9 subscales and it is possible to separate the questions into distinct
subscales that can be used on their own or in conjunction with additional questions from the
researchers. To retain reliability or validity of the measure, it is advisable that all the items of
each subscale that is adapted must be retained (UCL, 2011). The Cervical CAM is a validated
instrument that was developed by the UCL Health Behavior Research Centre, in
collaboration with the Department of Health Cancer Team and The Eve Appeal. It forms part
of the Cervical Cancer Awareness and Symptoms Initiative (CCASI). It is based on a generic
CAM developed by Cancer Research UK, University College London, King‟s College
London and Oxford University in 2007-2008. The CAM was developed in UK and the
revised by UCLS so that researchers could systematically assess the impact of interventions
designed to target gaps in public awareness of cancer either in whole populations or specific
sub-groups. Psychometric evaluation indicated that the instrument has satisfactory internal
consistency with Cronbach‟s alpha above 0.7 for all components (McCrae, Kurtz, Yamagata,
& Terracciano, 2011). Test-retest reliability was good with all correlations above 0.7 (Kline,
1993), Construct validity was done by cervical cancer experts, university administration staff,
and students.
The adapted knowledge instrument had 31 questions and consisted of 4 sub-scales
which included risk factors (13 items), signs and symptoms of cervical cancer (11 items),
prevention of cervical cancer (4 items) and awareness of cervical cancer, screening and HIV
(4 items). Out of the 31adapted knowledge items, 27 items were already translated into
Chichewa, the local language (Hami, Ehlers, & Van de Wal, 2012). The awareness sub-item
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consisted of 4 questions which were not translated including frequency of cervical cancer
examination in HIV-positive women; if the cancer can be cured and not HIV; and association
between HIV and cervical cancer. The knowledge about signs and symptoms of cervical
cancer include 11 questions about: vaginal bleeding, vaginal mass, weight loss, back pain,
and loss of appetite. The questions on risk factors include 13 questions on hormonal family
planning use, HIV/AIDS, washing/putting traditional medicine inside the vagina, family
history, smoking, early age of starting sex, and multiple sexual partners. The questions on
prevention of diseases included 3 questions about male circumcision, screening, and proper
and regular condom use.
Attitudes: The attitude about cervical cancer screening was measured by using
Knowledge, Attitude, and Practices Survey (KAP survey) developed by WHO (2008). The
KAP survey was developed as a sample guide questionnaire for conducting KAP surveys to
produce desired behavioral change and increased use of health services. The tool can be
adapted to a specific cultural context, different populations and behavioral change studies.
The tool has mostly been used in TB programs worldwide, including Malawi and in raising
awareness of the association between HIV and other communicable diseases WHO (2008).
The instrument was adapted in cervical cancer screening studies and validated in Kenya,
Malawi and Zimbabwe and the Cronbach‟s alpha ranged from 0.79-0.84 for all components
(Hami et al, 2012; Rositch et al, 2012; Matangaidze et al., 2016). In this study, the attitudes
about cervical cancer and screening were measured by adapting 5 attitude questions that were
included in the questionnaire. The questions were: if they fear screening procedure, feel shy
to expose private parts, afraid of pain or discomfort, afraid of bleeding, and afraid of
diagnosis. The adapted 5 items had already been translated into local language cervical
cancer studies in Malawi (Hami et al, 2012). These items were answered with responses of
“Yes,” “No,” or “Don‟t know.”
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Social Support Network. The studies done in developed countries like the U.S have
widely used a social network index (SNI) to understand social network and health behavior
studies (DalMaso et al., 2010; Wigfal et al., 2015). The SNI instrument assigns scores to the
participants based on the number or frequency of contacts and types of ties between the
respondent and members within the network (Cohen & Syme, 1985). The instrument does not
provide information regarding the characteristics of the members within the network. This
study adapted the Multidimensional Scale of Perceived Social Support (MSPSS) that was
developed by Zimet et al., 1988 in the USA. The MSPSS is a 12 item, self- administered
scale that assesses the perceived social support and includes emotional and instrumental
support to help make decisions. The internal consistency of the total scale and subscales is
consistently above .85 across studies with diverse samples. The scale has been used in
culturally and linguistically diverse samples including low-income populations, both in the
U.S. and Sub-Saharan Africa including Malawi (Bruwer, Emsley, Kidd, Lonchner, & Seedat,
2007; Malde et al., 2015; Nakigudde et al., 2009; Stewart et al., 2014). In Malawi, the generic
scale that was developed from the USA was validated among women attending an antenatal
clinic in Malawi. The total scale for Chichewa version had good internal consistency and the
Cronbach‟s alpha was 0.88 and was deemed to be a reliable scale to measure social support
networks within the Malawi setting (Stewart et al., 2014). The scale is already translated and
is available in local Chichewa language, but it was reviewed based on findings of the pilot
study to add the social networks that women living with HIV consider important for cervical
cancer screening. The instrument measures only positive dimensions of social support
networks in influencing behavior change. The instrument had 3 sub-scales which included 1)
Family with 4 items; 2) Friends with 4 items; and 3) health care providers with 3 items. The
scale uses a 7-point Likert scale: (1) very strongly disagree to (7) very strongly agree. The
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scoring of the MSPSS varies based on culture. For this study, the participants answered
“Yes” or “No” or “Don‟t know” to the question.
Access to Health Care Services. The access to cervical cancer screening services
was measured by World Health Survey instrument (WHO, 2002). The tool was developed by
WHO to compile comprehensive baseline health information of the population for 70
countries in the world including Malawi. The instrument was intended to be used in different
cultures and settings. There was no evidence that the tool was validated in Malawi, but the
instrument had been used in most health care access studies in Malawi and Sub-Saharan
Africa (Akinyemiju, McDonald, & Lantz, 2015). The adapted access to health care services
has 5 subscales with 12 items. The 5 sub-scales include affordability with 1 item; availability
with 2 items; accessibility with 2 items; accommodation with 4 items; and acceptability with
3 items. The 8 items were translated into Chichewa and pretested. These items are answered
with responses of “Yes,” “No,” or “Don‟t know.”
Consent Procedure
The initial consenting was done in person by the researcher and the trained research
assistants (RAs). Five RAs were recruited and two days of training (Refer to Attachment E)
was offered to educate the RAs on research methods, to support eligible research participants
to make informed decisions about participation in the study, and to practice interviewing
participants. The training was conducted by the researcher and supervised by the research
supervisor to ensure the quality of training. Participants were given a written informed
consent (Refer to Attachment F) to sign for participation after determining that they met the
inclusion criteria in their prefered language. The researcher and RAs provided a verbal
explanation of the study that described the study purposes, processes, confidentiality of
information, benefits and risks, and the right to withdraw from the study. The participants
were asked to repeat the information to ensure that they understand the study‟s purpose.
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Participants signed an informed consent statement after all their questions about the study
were answered to their satisfaction. For participants who could not write, a thumb stamp
served as a signature. The signed consents were kept in a locked cupboard separate from
other records at the study site.
Risks and Benefits. The primary risk associated with this study was no more than
minimal, but some questions might have caused discomfort, embarrassment or psychological
harm. There were no direct medical benefits to participating in this study, but the results from
the study will help to develop an evidence-based intervention to promote cervical cancer
screening programs among HIV-positive women to prevent cervical cancer so that HIVpositive women may live a more productive life. Participants were offered indirect benefit of
the value of MK4, 000 equivalents to $5 US dollars in the form of a gift card in recognition
of their commitment of time and their submission to the discomfort caused by some
questions. The United States Commission‟s Belmont Report (1978) indicated that indirect
benefits of financial incentives for the participants are indirect as they do not stem from the
research interventions themselves, but the subjects may view them as very important and may
be acknowledged but should not be assigned heavy weight (USA, Belmont Report, 1878).
Data Collection
A 30 to 45 minute face-to-face interviewer-administered questionnaire (Refer to
Attachment G) was conducted in local Chichewa language or English based on participants‟
preference time and dates. Recruitment anouncements (Refer to Attachment H) and
appointments regarding the research purposes, confidentiality of information, the right to
withdraw from the study, contacts and where the interview would take place were made
during HIV support group meeting days by the expert client or support group coordinator.
Volunteers who showed up for participation in the study during the scheduled days were
recruited consecutively. The survey was administered by the researcher and RAs after
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obtaining women‟s signature on the informed consent form. The interviewer read the
questions and responses to the questions exactly as they were worded in the questionnaire to
the participants to make sure that the participants understood the question and were given
time to give a response to the question before proceeding to the next question. The
interviewer marked the response to the question on behalf of the respondent. The women
could not answer the questions on their own as most of them could not read and write. The
advantage of face-to-face interviewer adminstered questionnare was that the interviewer
could help the participant understand the question, therefore, more accurate information and
quality data were collected (Polit & Beck, 2011). The disavantages of face-to-face interviews
include interviewer bias, it is time consuming, and participants might feel uneasy about the
confidentiality of their responses (Polit & Beck, 2011). Inorder to overcome these
challenges, five RAs were trained and assisted in data collection, data was collected at the
support group planned meeting day, participation was voluntary, results were reported using
code numbers and in aggregate form. The data collection process continued until the sample
size was reached.
Ethical Considerations
Ethical clearance to conduct a study was saught from Lilongwe Rural and Lilongwe
Urban district offices, University of Massachusetts Boston, and National Health Sciences
Research Committee (NHSRC) in Malawi (Refer to Attachement I). Permission to access the
register of the list of all HIV positive support groups was obtained first from the Lilongwe
Rural and Lilongwe Urban district offices (Refer to Attachement J). Then permission was
obtained University of Massachusetts Boston and lastly from the National Health Sciences
Research Committee (NHSRC) in Malawi. In Malawi, the National IRB approves protocols
after the protocol has been approved by the student‟s training institution and or research site.
All eligible women were informed that their decision to participate in this study was not to
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affect their access to healthcare services. To ensure confidentiality, each participant was
assigned a code number, which was stored in a locked desk. There was no link between
names, codes, and responses.
Data Analysis
The data were analyzed using Statistical Package for Social Science (SPSS
Version21; IBM, Armonk, NY) software. To maintain high quality data, the collected data
was cleaned and checked for completeness. Frequencies were computed on all variables and
checked for distribution, missing values, and errors (Enders, 2010).
Data was analyzed according to concepts of the framework including participant‟s
demographic characteristics, cervical cancer screening rate, level of knowledge, attitudes,
social support networks, and access to cervical cancer screening.
Demographic characteristics. There were 8 questions on socio-demographic details
of HIV-positive women which include age, marital status, education level, occupation,
income, religion, number of pregnancies, and when they were diagnosed with HIV. During
the analysis, the marital status was categorized as 1) married and 2) single (this category
included not married, divorced, and others). Age was treated as a continuous variable and as a
categorical variable. There were two categories including 18-29 and above 30 years.
Education level was categorized as an ordinal variable with category option of: 1) never
attended or primary level, 2) secondary level and university level. Occupation was
categorized as 1 implying not working and 2 implying working. Women‟s monthly income
status was treated a categorical variable 1) <$100 and 2) >$100. The number of years since
HIV diagnosis was treated as a continuous variable. The number of pregnancies that the
women had ever had was treated as a continuous variable. Religion was categorized as 1)
Christian and 2) Other which included Moslems, Gulewamkulu, and those not going to
church.
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Cervical Cancer Screening. Cervical cancer screening was the primary outcome of
the study and was dichotomous response indicating whether the respondents had ever had
cervical cancer screening or not. It was coded 1 to indicate ever had screened after HIV
diagnosis and 0 never had screening.
Individual Factors. The individual factors had two sub-scales: knowledge and
attitude. The overall score for knowledge regarding cervical cancer and cervical cancer
screening was calculated. Each correct response scored one point and wrong response or “I
do not know” response scored zero. The individual correct scores varied between 0-31. The
composite score of knowledge was used to measure knowledge level. The cumulative mean
score of knowledge of participants about cervical cancer and screening was estimated using
mean score as a cut-off point. The total correct scores less than the mean score meant that the
women had low levels of knowledge regarding cervical cancer and screening. Scores above
the mean score meant that the women had high levels of knowledge regarding cervical cancer
and screening.
Attitudes: An overall score of attitude about cervical cancer and screening were
calculated as the sum of positive responses. If the individual response was positive towards
cervical cancer screening, one point was given. If the response was negative or “I do not
know,” zero point were given. The individual correct scores varied between 0-6. The
descriptive and inferential statistics were calculated, and the mean score was reported. The
scores less than the mean score meant that the women had a negative attitude regarding
cervical cancer screening and scores above the mean score, meant that the women have a
favorable attitude regarding cervical cancer screening.
Social Support Network. The overall score for social support staff regarding cervical
cancer screening was calculated. Each response indicating the availability of social support
regarding cervical cancer screening scored one point and those with no social support
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response or “I do not know” response scored zero. The individual scores were summed for
the total score. The individual scores varied between 0-11. The descriptive and inferential
statistics were calculated, and the mean scale score was reported. The higher the score above
the mean indicated higher levels of perceived social support from networks (Calvete &
Cannor-Smith, 2006).
Access to Health Care Services. The overall score for access to health care services
regarding cervical cancer screening was calculated. Each response indicating having access to
cervical cancer screening scored one point and those with no access to screening or “I do not
know” response scored zero. The individual correct scores varied between 0-12. The
descriptive and inferential statistics were calculated, and the mean score was reported. The
higher the score above the mean indicated easy access to health care services and the scores
below the mean indicated difficulties accessing health care services (WHO, 2002).
Reliability analysis was performed to measure the overall consistency of the items of
the instrument. Figure 5 is the statistical model for data analysis for specific aims 1 to 3.

Figure 5. Statistical Model of Cervical Cancer Screening among HIV Positive Women
Specific Aim 1. Descriptive statistics were computed to describe the status of cervical
cancer screening behavior and level of knowledge and attitude among Malawian women
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living with HIV infection on all variables. The sum of each scale, means with standard
divisions or percentages were computed as appropriate to each measure. Using paired t-test or
Chi-square when appropriate, we explored the extent to the screened and non-screened
women differed from each other in their awareness, knowledge, attitudes, social support
networks, and accessto cervical cancer screening. The significance level was set at p <0.05.
groups.
Specific Aim 2. Bivariate logistic regression analysis were conducted to explore the
relationship between each determinant (age, education, marital status, employment, income,
knowledge, attitudes, social support network, and access to health care) with cervical cancer
screening. The adjusted Odds Ratios (OR) and their corresponding 95 percent CI were used
to measure the strength of associations between independent variables and outcome variable
(cervical cancer screening). A two-tailed p-value of < .05 was considered statistically
significant.
Specific Aim 3. To examine whether knowledge and attitudes are independently
associated with cervical cancer screening after controlling for other determinants of cervical
cancer screening (occupation, income, social support network, and access to health care
services). Multivariable logistic regression analyses were conducted by entering into the
model the independent variables that were statistically significant in bivariate analysis. The
adjusted Odds Ratios (OR) and their corresponding 95 percent CI were used to measure the
strength of associations between knowledge and attitudes, and cervical cancer screening after
adjusting for other covariates.
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CHAPTER 4
RESULTS
This chapter presents information of the study participants‟ basic demographic
characteristics, screening behavior, knowledge and attitude regarding screening, social
support networks, and access to screening services following the study specific aims.
Specific Aim 1. The specific aim 1 was to describe the status of cervical cancer
screening behavior and level of knowledge and attitude among Malawian women living with
HIV infection.
Socio-demographic Characteristics of the Respondents
The study approached 291participants and all women agreed to be interviewed giving
a response rate of 100%. A 100% response rate might be due to conducting interviews during
their meeting days within their community, gift cards, and face-to-face interviews with the
respondents. The participants‟ socio-demographic characteristics are summarized in Table 9.
Table 9
Basic Characteristics of the of Respondents
Variable

N=291

(%)

Geographical location
Rural
Urban

116
175

39.9
60.1

Occupation
Working

10

3.4

281

96.6

267

91.8

24

8.2

33
137
121

11.3
47.1
41.6

61
170
55
5

21
58.4
18.9
1.7

Not Working
Religion
Christian
Others
Marital Status
Single (Never married)
Married
Divorced/widowed
Education Level
Never attended school
Primary Level
Secondary level
College
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Monthly Family Income
< $100
>$100

258
33

88.7
11.3

Age in years
18-29 years
30-60 years

117
174

40.2
59.8

Age
Pregnancies
Time since HIV diagnosis (years)

Range
18-60
0-15
1 to 19

Mean (SD)
34.81 ± 9.85
4.5± 2.58
7.16 ± 4.2

The results in Table 9 indicate that the age of the respondents ranged from 18 – 60
years (M 34.81, SD = 9.85). Out of the total 291 respondents, 117 (40.2%) were aged18-29
years and 174 (59.8%) were aged 30-60 years. The number of years since diagnosed with
HIV infection ranged from 1to 19 years (M=7.16, SD 4.2). The number of pregnancies
reported ranged from 0-15 (M 4.50, SD = 2.58). Out of the 291 women, 137 (47.1%) were
married, 121 (41.6%) were either divorced or widowed, and the remaining 33 (11.3%) were
single, which is they had never been married before. The majority: 281 (96.6%) of the
respondents were not working; 267 (91.8%) were Christians; 175 (60.1%) were from urban;
and 255 (88.5%) their monthly family income was <$100. The education level varied: 61
(21%) never attended; 170 (58.4%) had primary education; 55 (18.9%) had secondary
education; and 5 (1.7%) went to college. The majority of the respondents were from urban
areas, aged between 30-60 years, single, not working, low monthly family income, and of
low education level.
Cervical Cancer Screening Behavior
Cervical cancer screening behavior was assessed by screening status, screening
method, and when the screening was done (before HIV diagnosis or after HIV diagnosis) as
in Figure 6.
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Figure 6. Cervical Cancer Screening Behavior
The results in Figure 6 shows that 96 (33%) of the respondents had cervical screening
while 195 (67%) of the respondents did not have screening. Further the results indicated that
only 81 (27.8%) had cervical cancer screening after HIV diagnosis. Therefore, the prevalence
of cervical cancer screening in women living with HIV infection in Lilongwe was 27.8%,
with confidence interval (22.7%, 32.9%). Out of the 96 respondents who received cervical
cancer screening, 94 (97.9%) had VIA as a screening method and 2 (2.1%) had both VIA and
Pap smear as screening methods.
Knowledge about Cervical Cancer and Screening
Knowledge regarding cervical cancer screening included risk factors of developing
cervical cancer, signs and symptoms of cervical cancer, prevention of cervical cancer, and
awareness of cervical cancer as indicated in Table 10.
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Table 10
Knowledge about Cervical Cancer and Screening
A. Risk factors of developing cervical cancer = N (%)

Overall
291 (%)

Screened
81(%)

Not
screened
210 (%)

Smoking

146(50.2)

42 (51.9)

104 (49.5)

Having many sexual partners

259(89)

79(97.5)

180 (85.7)

259(89)

80 (98.8)

179 (85.2)

258(88.7)
242(83.2)

78 (96.3)
75 (92.6)

180 (85.7)
167 (79.5)

267(91.8)

80 (98.8)

187 (89)

252(86.6)
264(90.7)
152(52.2)
260(89.3)
165(56.7)
249(85.6)
209(71.2)

79 (97.5)
80 (98.8)
50 (61.7)
79 (97.5)
51 (63)
71 (87.7)
64 (79)

173 (82.4)
184 (87.6)
102 (48.6)
181 (86.2)
114 (54.3)
178 (84.8)
145 (69)

Mean +SD
(range)
10.25+3.12
(0-13)

Mean +SD
(range)
11.21+1.66
(5-13)

Mean +SD
(range)
9.88+3.46
(0-13)

Vaginal bleeding between periods
Menstrual periods that are heavier or longer than usual
Vaginal bleeding after the menopause
Vaginal bleeding during or after sex
Excessive vaginal discharge that smells unpleasant
Vaginal itching or irritation
Pain or discomfort during sexual intercourse
Lower back pain
Pelvic pain
Frequent urination
Unexplained weight loss

Overall
291 (%)
258(88.7)
261(89.7)
260(89.3)
257(88.3)
269(92.4)
250(85.9)
262(90)
235(80.8)
248(85.2)
187(64.3)
176(60.5)

Screened
81(%)
80 (98.8)
78 (96.3)
76 (93.8)
78 (96.3)
81 (100)
73 (90.1)
80 (98.8)
71 (87.7)
77 (95.1)
59 (72.8)
53 (65.4)

Not
screened
210 (%)
178 (84.8)
183 (87.1)
184 (87.6)
179 (85.2)
188 (89.5)
177 (84.3)
182 (86.7)
164 (78.1)
171 (81.4)
128 (61)
123 (58.6)

Knowledge regarding signs and symptoms
Cronbach‟s Alpha (11 items)

Mean +SD
(range)
9.15+2.82
(0-11)
0.9

Mean +SD
(range)
9.95+1.60
(4-11)

Mean +SD
(range)
8.84+3.12
(0-11)

Do you think the following factors may increase the
woman’s chance of developing cervical cancer?

Having a sexual partner with many previous sexual
partners
Having a sexual partner who is not circumcised
Having sex at an early age
Having a weakened immune system (because of
HIV/AIDS)
Infection with HPV (Human Papilloma Virus)
Having sexually transmitted infection
Having a family member diagnosed with cancer
Inserting traditional medicine into the vagina
Taking family planning pills for a long time
Having many children
Not going for regular screening

Knowledge regarding risk factors
Cronbach‟s Alpha (13 items)

0.87

B. Signs and Symptoms of Cervical Cancer = N (%)
Do you think the following are signs and symptoms of
cervical cancer?
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C: Prevention of Cervical Cancer = N (%)
Can the following actions prevent cervical cancer?

Overall
291 (%)

Screened
81(%)

Male circumcision
Cervical cancer screening (examining the cervix)
Proper and regular condom use
HPV Vaccination

265(91.1)
254(87.3)
257(88.3)
240(82.5)

80 (98.8)
78 (96.3)
77 (95.1)
68 (84)

Not
screened
210 (%)
185 (88.1)
176 (83.8)
180 (85.7)
172 (81.9)

Mean +SD
(range)
3.49+1.05
(0-4)

Mean +SD
(range)
3.74+0.61
(1-4)

Mean +SD
(range)
3.40+1.16
(0-4)

Overall
291 (%)

Screened
81(%)

Not
screened
210 (%)

271(93.1)

77 (95.1)

194 (92.4)

278(95.5)

80 (98.8)

198 (94.3)

247(84.9)

75 (92.6)

172 (81.9)

Mean +SD
(range)
2.74+0.64
(0-3)

Mean +SD
(range)
2.86+0.44
(1-3)

Mean +SD
(range)
2.69+0.70
(0-3)

Mean +SD
(range)
25.63+6.35
(0-31)
0.93

Mean +SD
(range)
27.77+3.03
(18-31)

Mean +SD
(range)
24.80+7.07
(0-31)

Knowledge regarding prevention of cervical cancer

D: Awareness about Cervical Cancer, screening and HIV = N (%)

A woman who is HIV positive should undergo cervical
cancer screening at least once per year.
A woman who is HIV positive is at higher risk of
developing cervical cancer than a woman who is HIV
negative.
Cervical cancer develops slowly and can be cured if
detected early
Awareness regarding cervical cancer and screening

Overall Knowledge
Knowledge regarding cervical cancer and screening
Cronbach’s Alpha (31 items)

The results in Table 10 show that the overall knowledge score ranged from 0-31of
correct answers (M =25.63, SD = 6.35) with minimum total score of 0 and maximum score of
31. The overall results show that the respondents were knowledgeable about cervical cancer
and screening. However, knowledge of the respondents was higher in respondents who were
screened (M = 27.77, SD = 3.03) with a range of 18-31scores of correct responses than the
respondents who were not screened (M = 24.80, SD = 7.07) with a range of 0-31 scores of
correct responses.
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The overall results show that most women knew the risk factors for developing
cervical cancer (M = 10.25, SD = 3.12). The knowledge score about the risk factors of
cervical cancer was higher in respondents who were screened (M = 11.21, SD = 1.66) with a
range of 5-13 of correct responses than the respondents who were not screened (M = 9.88, SD
= 3.46) with a range of 0-13 of correct responses. The majority of the respondents, 264
(91.8%), indicated that having a weakened immune system because of HIV/AIDS and having
sexually transmitted infection, 264 (90.7%), have increased risk for developing cervical
cancer. On the other hand, almost half of the respondents identified that smoking, 146
(50.2%), having a family member diagnosed with cancer, 152 (52.2%), and taking family
planning pills for a long time, 165 (56.7%), increases the woman‟s risk of developing
cervical cancer.
The overall respondent‟s knowledge about the signs and symptoms of cervical cancer
ranged from 0-11scores (M = 9.15, SD = 2.82). This shows that, overall, the respondents were
knowledgeable about the signs and symptoms of cervical cancer. However, the knowledge
about the signs and symptoms about cervical cancer was higher in women who were screened
(M = 9.95, SD = 1.60) with a range of 4-11scores than those who were not screened (M =
8.84, SD = 3.12) with a range of 0-11 scores. A majority, 269 (92.4%) of the respondents
indicated that excessive vaginal discharge that smells unpleasant and pain or discomforts
during sexual intercourse, 262 (90%), were the main signs and symptoms of cervical cancer.
In addition, 261 (89.7%), of the respondents indicated that menstrual periods that are heavier
or longer than usual and vaginal bleeding after menopause, 260 (89.3%), were also signs and
symptoms of cervical cancer. On the other hand, only 176 (60.5%), of the participants were
able to identify that unexplained weight loss was a possible sign of cancer.
The overall respondent‟s knowledge of possible prevention strategies for cervical
cancer ranged from 0-4 scores (M = 3.49, SD = 1.05). The overall results indicate that the
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women were knowledgeable about the prevention strategies of cervical cancer. However, the
mean knowledge score was higher in women who were screened (M = 3.74, SD = 0.61) with
a range of 1-4 scores than those who were not screened (M = 3.40, SD = 1.16) with a range of
0-4 scores. A majority, 265 (91.1%), of the respondents identified male circumcision
correctly as a prevention strategy of cervical cancer, followed by proper and regular condom
use 257 (88.3%), cervical cancer screening 254 (87.3%), and HPV vaccination 240 (82.5%).
The overall participant‟s awareness score about cervical cancer, screening, and HIV
ranged from 0-3 (M = 2.74, SD = 0.64). The overall results indicate that the respondents were
aware of the link between cervical cancer and HIV. However, the awareness about cervical
cancer, screening, and HIV was higher for respondents who were screened (M = 2.86, SD =
0.44) with a range of 1-3 scores than the respondents who were not screened (M = 2.69, SD =
0.70) with a range of 0-3 scores. A majority, 278 (95.5%) correctly indicated that a woman
who is HIV positive is at a higher risk of developing cervical cancer than a woman who is
HIV negative. Further, a majority, 271 (93.1%), identified that a woman who is HIV positive
should undergo screening at least once per year. Lastly, a majority, 247 (84.9%) identified
that cervical cancer develops slowly and can be cured if detected early.
The internal consistency of the instrument was measured by Cronbach‟s alpha. The
Cronbach‟s alpha for knowledge of participants on cervical cancer, screening, and HIV were:
for risk factors for 13 items, Cronbach‟s alpha was 0.87; signs and symptoms for 11 items
Cronbach‟s alpha was 0.90. The internal consistency for sub-items of knowledge about
awareness and prevention about cervical cancer was not measured as they had items of less
than 5. The overall Cronbach‟s alpha for the instrument for knowledge with 31 items was
0.93. This means that all items for knowledge regarding cervical cancer and screening had
good internal consistency.
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Attitude Regarding Cervical Cancer Screening
The attitude regarding cervical cancer screening is summarized in Table 11.
Table 11
Attitude Regarding Cervical Cancer Screening
N (%)

What is your opinion on these questions

Overall
291 (100)

Screened
81(00)

Not
screened
210 (100)

1

Do you fear cervical Cancer screening procedure?

54(18.6)

8 (9.9)

46 (21.9)

2

Do you feel shy to expose your private parts during the
procedure to young or male service providers?

49(16.8)

11 (13.6)

38 (18.1)

3

Are you afraid of pain/discomfort during cervical cancer
screening procedure?

54 (18.6)

5 (6.2)

49 (23.3)

54 (18.6)

6 (7.4)

48 (22.9)

45 (15.5)

11 (13.6)

34 (16.2)

Mean
+SD
(range)

Mean
+SD
(range)

Mean +SD
(range)

4.12+1.33
(0-5)
0.74

4.49+1.04
(0-5)

3.98+1.41
(0-5)

4
5

Are you afraid of bleeding during and after cervical cancer
screening procedure?
Are you afraid of being diagnosed with cervical cancer after
undergoing the screening?

Attitude regarding cervical cancer screening
Cronbach’s Alpha (5 items)

The findings in Table 11 indicate that the overall respondent‟s attitude score about
cervical cancer screening ranged from 0-5 (M = 4.12, SD = 1.33). This shows that, overall,
the respondents had a positive attitude regarding screening. However, the respondent‟s
attitude regarding screening, was higher in women who were screened (M = 4.49, SD = 1.04)
with a range of 0-5 scores of correct responses than those who were not screened (M = 3.98,
SD = 1.41). The overall results indicate that few, 54 (18.6%) feared cervical cancer
procedure, were afraid of pain/discomfort during screening procedure, and were afraid of
bleeding during or after the procedure. However, comparing the respondents who were
screened to those who were not screened, those who were not screened, 46 (21.9%), feared
cervical cancer screening procedure compared to respondents who were screened, 8 (9.9%).
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Overall, the majority of the respondents did not fear the procedure, were not shy to expose
the private parts, were not afraid of the diagnosis, and were willing to be screened.
The internal consistency of the instrument for attitude scale with 5 items had a
Cronbach‟s alpha of0.74. This means that all the items for attitude regarding screening had
acceptable reliability measures. The possible reason for low Cronbach‟s alpha might be due
to less number of items.
Comfortability during screening. Women were further asked whom they would be
comfortable to perform screening on them between male and female service providers. The
women‟s responses are illustrated in Figure 7.

Figure 7. Whom women would be comfortable with
The results in Figure 7 indicate that the majority, 204 (70.1%) of the respondents would
be comfortable to be screened by both male and female providers, 75 (25.8%) by female
service providers, 12 (4.1%) were not comfortable with either of them (male or female
providers).
Social Support Networks
Table 12 describes respondent‟s social support networks regarding cervical cancer
and screening.
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Table 12
Social Support Networks
Item
Overall
291 (%)

Yes = N (%)
Not
Screened
screened
81(%)
210 (%)

Health care providers
1

Is the health care provider always available when you need
cervical cancer screening services?

2

Can you share your concerns about cervical cancer screening
with a health care provider?

3

4
5
6

Have health care providers ever counseled (talked to) you
about cervical cancer screening?
Family members
Does your family try to help you with financial support to go
for cervical cancer screening?
Do you get the emotional help and support you need from
your family regarding HIV and cervical cancer screening?
Can you discuss about cervical cancer screening with your
family?

7

Have your family members ever encouraged you to go for
cervical cancer screening?
Friends

8

Have your friends ever recommended to you cervical cancer
screening?
Can your friends provide social support when found
(diagnosed) with cervical cancer?

9
10

Do you have friends with whom you can share your results
of screening (examination)?

11

Can you encourage your friend to go for cervical screening?

Social Support Networks
Cronbach‟s Alpha (11 items)

166 (57)

63 (77.8)

103 (49)

214
(73.5)

65 (80.2)

149 (71)

224 (77)

72 (88.9)

152 (72.4)

66 (22.7)

33 (40.7)

33 (15.7)

157 (54)

58 (71.6)

99 (47.1)

71 (87.7)

165 (78.6)

69 (85.2)

144 (68.6)

67 (82.7)

154 (73.3)

69 (85.2)

166 (79)

77 (95.1)

191 (91)

79 (97.5)

198 (94.3)

Mean
+SD
(range)

Mean
+SD
(range)

Mean +SD
(range)

7.82+2.67
(0-11)
0.81

8.93+2.21
(0-11)

7.40+2.71
(0-11)

236
(81.1)
213
(73.2)
221
(75.9)
235
(80.8)
268
(92.1)
277
(95.2)

The results in Table 12 indicate that the overall respondent‟s social support networks
score about cervical cancer screening ranged from 0-11 (M = 7.82, SD = 2.67). This shows
that, overall, the respondents had social support networks that influence screening bahavior.
However, the respondent‟s social support networks score regarding screening, was higher in
women who were screened (M = 8.93, SD = 2.21) with a range of 0-11 scores than those who
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were not screened (M = 7.40, SD = 2.71). For the women who were screened, a majority, 66
(77.8%) indicated that the health care providers were always available when they needed
screening services whilst those not screened, almost half of the respondents, 103 (49%)
indicated that the health care providers were not always available when they needed
screening services. The overall results indicate that only one-fifth, 66 (22.7%), of the
participants indicated that family members tried to help them with financial support, and 157
(54%) of the women got emotional support from family members. The results indicate that
family members may not be able to provide all the financial and emotional support that might
be needed.
The internal consistency of the instrument for social support network scale with 11
items had a Cronbach‟s alpha of 0.81. This means that all the items for social support
network regarding screening had good reliability measures.
Access to Cervical Cancer Screening Services
Table 13 describes respondent‟s access to cervical cancer screening services.
Table 13
Women's Access to Cervical Cancer Screening
What are the reasons that best explain why you did not get the examination for cervical
cancer?
N (%)
Not
Overall
Screened
screened
Affordability
291 (%)
81(%)
210 (%)
1
2
3
4
5
6
7
8
9

No money for transport
Availability
Did not know where to go for screening
Screening sites are far (distance)
Accessibility
Previously, I was badly treated
Long waiting time
Accommodation
The health care providers are inadequate
There were no equipment and supplies
I thought I was not sick
Could not take time off my work/had other
commitments/laziness
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116 (39.9)

17 (21)

99 (47)

59 (20.3)
79 (27.1)

9 (11.1)
11 (13.6)

50 (23.8)
68 (32.4)

19 (6.5)
67 (23)

3 (3.7)
18 (22.2)

16 (7.6)
49 (23.3)

21 (7.2)
24 (8.2)
78 (26.8)

5 (6.2)
6 (7.4)
12 (14.8)

16 (7.6)
18 (8.6)
66 (31.4)

46 (15.8)

7 (8.6)

39 (18.6)

10
11
12

Acceptability
There is no privacy at the clinic
Providers are males
I do not see the reason to go for screening as I am too
old/too young

Access to screening
Cronbach‟s Alpha (12 items)

2 (0.7)
14 (4.8)

0
4 (4.9)

2 (1)
10 (4.8)

18 (6.2)

2 (2.5)

16 (7.6)

Mean +SD
(range)
10.13+1.93
(3-12)
0.67

Mean +SD
(range)
10.84+1.98
(4-12)

Mean+SD
(range)
9.86+1.84
(3-12)

The overall findings in Table 13 show that only 96 (33%) of the women received
screening the last time they needed it. Some women did not access cervical cancer screening
services due to no money for transport 116 (39.9%) (affordability), long distance to screening
facility 79 (27.1%) and some did not know where to go 59 (20.3%) (availability), thought that
they were not sick 78 (26.8%) (accommodation), and long waiting time 67 (23.0%)
(accessibility). Very few 18 (6.2%) stated that they did not see the reason to go for screening
as they were either too old or too young and 14 (4.8%) indicated that service providers are
males (acceptability).
The overall respondent‟s score to access to screening services ranged from 3-12 (M =
10.13, SD = 1.93). This shows that, overall, the respondents had access to screening services.
However, the respondent‟s access to screening services score was higher in women who were
screened (M = 10.84, SD = 1.98) with a range of 4-12 scores than those who were not
screened (M = 9.86, SD = 1.84). The internal consistency of the instrument for access to
screening services scale with 12 items had a Cronbach‟s alpha of 0.67. The possible reason
for low Cronbach‟s Alpha might be due to the wording of the questions as they were
negatively worded as compared to knowledge and social support network domains.
The internal consistency of the instrument for whole instrument with 4 subscales:
knowledge with 31 items, attitude with 5 items, social support network with 11 items, and
access to screening with 12 items had Cronbach‟s alpha of 0.88. This means that the overall
instrument had good Cronbach‟s alpha.
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Mode of transport and travel time. The women were asked how they travel (mode
of transport) to clinics for HIV and screening services, and how long they take to reach a
health facility as indicated in Table 14.
Table 14
Mode of Transport and Travel Time
How do you travel when going to the clinics (HIV and
cervical cancer screening)?
Bicycle/walk
Public transport
How long does it take to get to the clinic from where you
live?
Less than 30 minutes
More than 30 minutes

n
187
104

%
64.3%
35.7

n
52

%
17.9%

239

82.1

The results in Table 14 indicate that the common mode of transport was
bicycle/walking 187 (64.3%) seconded by public transport 104 (35.7%). The majority, 239
(82.1%) of the respondents took more than 30 minutes to go to a health care facility and 52
(17.9%) took less than 30 minutes. The results indicate that the majority walk and takes more
than 30 minutes to access health care services.
Type of a facility. For respondents who had screening, they were asked where they
go for screening services as indicated in Table 15.
Table 15
Type of facility

Where did you go for cervical cancer screening?
Government Health Facility
Non-Government

n=96

n
76
20

%
79.2%
20.8%

The findings in Table 15 indicate that the majority 76 (79.2%) who were screened
went to Government health facilities and few 20 (20.8%) went to Non-Governmental, either
CHAM or private health facilities.
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Specific Aim 2: To explore the factors associated with cervical cancer screening
behavior among Malawian women with HIV infection.
Factors Associated with Cervical Cancer Screening Behavior
Table 16 presents the odds ratio associated with cervical cancer screening behavior
for unadjusted and adjusted models. Model 1 presents the raw effect for unadjusted simple
logistic regression and model 2 presents the adjusted multivariate logistic regression.
Table 16
Odds Ratio Associated with Screening
OR (CI)
Raw Mode 1
Location
Rural
Urban

Reference
1.59
(0.92, 2.72)

Adjusted
OR Model 2

P-value

5.12
(1.07, 24.43)

0.041

0.094
0.211

Religion
Other religion
Christian

P-value

Reference
0.49
(0.16, 1.49)

Age
18-29 years
30-60 years
Marital Status
Single
Married
Education Level
Never attended/ Primary
Secondary/College
Occupation
Not Working
Working
Monthly Income
<$100
>$100
Time since HIV diagnosis (Years)
Number of Pregnancies
Knowledge

Reference
1.12
(0.66, 1.89)

0.676

Reference
1.06
(0.64, 1.77)

0.820

Reference
1.39
(0.76, 2.57)

0.287

Reference
6.53
(1.65, 25.90)

0.008

Reference
2.23
(1.01, 4.72)
1.05
(0.99, 1.12)
1.07
(0.97, 1.18)
1.12
(1.05, 1.20)
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0.04

1.65
(0.56, 4.12)

0.289

0.099
0.166
0.001

1.10
(1.02, 1.19)

0.012

Attitude
Social Support Network
Access

1.46
(1.14, 1.84)
1.14
(1.17, 1.53)
1.40
(1.17, 1.68)

0.002
0.001
0.001

1.36
(1.04, 1.76)
1.14
(0.99, 1.32)
1.21
(1.01, 1.44)

0.023
0.075
0.036

In Table 16, the results for the unadjusted model 1 of the logistic regression indicate
that geographical location (OR=1.59; 95% CI: .92, 2.72), religion (OR=0.49; 95% CI: 0.16,
1.49), age (OR=1.12; 95% CI: 0.66, 1.89), marital status (OR=1.06, 95% CI: 0.64, 1.77),
education level (OR=1.39; 95% CI: 0.76, 2.57), number of years with HIV diagnosis
(OR=1.05, 95% CI: 0.99, 1.12), and number of children (OR=1.07, 95% CI: 0.97, 1.18) were
not statistically significantly associated with cervical cancer screening behavior.
Women who were working were 5.5 times more likely to undergo screening than
women who were not working (OR=6.53; 95% CI: 1.65, 25.90). Women who had monthly
income of more than $100 were 1.2 times more likely to undergo screening than women who
had monthly income of less than $100 (OR=2.23; 95% CI: 1.1, 4.72).
When the knowledge score increases by 1 unit, the women are 12% more likely to go
for screening services (OR=1.12; 95% CI: 1.05, 1.20). With 1 point increase in attitude score,
the women are 45% more likely to go for cervical cancer screening services (OR=1.45; 95%
CI: 1.14, 1.84). When social support network score increases by 1 unit, the women are 34%
times more likely to have cervical cancer screening (OR=1.34; 95% CI: 1.17, 1.53). With 1
unit increase in access to screening services, the women are 40% more likely to go for
screening services (OR=1.40; 95% CI: 1.17, 1.68).
Therefore, in the unadjusted model, the likelihood of cervical cancer screening was
associated with occupation, income, knowledge, attitude, social support network, and access
to health care services. On the other hand, geographical location, religion, age, marital status,
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education, number of years with HIV diagnosis, and number of children were not found to be
associated with screening uptake.
Specific aim 3. To examine whether knowledge and attitudes are independently
associated with cervical cancer screening after controlling for other determinants of cervical
cancer screening.
In adjusted Models 2, the model examined whether knowledge and attitudes are
independently associated with cervical cancer screening after controlling for other
determinants of cervical cancer screening (occupation, income, social support network, and
access to health care services).
Knowledge of cervical cancer and screening. In the adjusted model 2, the odds ratio
of screening for knowledge was 1.10 (95% CI: 1.02, 1.19). It means that with 1 unit increase
in knowledge score, the women are 10% more likely to go for screening services. Therefore,
knowledge is independently associated with cervical cancer screening after adjusting for
occupation, income, social support network, and access to health care services.
Attitude. In the adjusted model 2, the odds ratio of screening for attitude was 1.36
(95% CI: 1.04, 1.76). It means that with 1 unit increase in attitude score, the women are 36%
more likely to go for screening services. Attitude is independently associated with cervical
cancer screening after adjusting for occupation, income, social support network, and access to
health care services.
Access to cervical cancer screening services. In the adjusted model 2, the odds ratio
of screening for access to screening services was 1.21 (95% CI: 1.01, 1.44).

It means that

with 1 unit increase in access to screening services, women are 21% more likely to go for
screening services. Therefore, access to screening services was independently associated
with cervical cancer screening after adjusting for other covariates.
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Social support networks. In the adjusted model 2, the odds ratio of screening for
social support network was1.14 (95% CI: 0.99, 1.32). Social support network is marginally
significant after adjusting for respondents‟ occupation, knowledge, attitude, income, and
access to screening services.
Therefore, in the full model 2, occupation (OR=5.12; 95% CI: 1.07, 24.43),
knowledge (OR=1.1; 95% CI: 1.02, 1.19), attitude (OR=1.36; 95% CI: 1.04, 1.76), and
access to screening services (OR=1.21; 95% CI: 1.01, 1.44) were independently associated
with cervical cancer screening.
Improving Screening Services
Women were asked on how the screening uptake can be improved. Figure 8 indicates
the women‟s responses.

Figure 8. Suggestions on increasing screening uptake
The results in Figure 8 indicate that women suggested that to increase screening
uptake, more health care providers should be trained in screening so that screening should be
done in HIV support groups or in the community, 177 (60.82%); others,108 (37.1%),
indicated that health education regarding cancer and screening should be intensified in the
community. Few, 4 (1.38%) indicated that government should provide cervical cancer
screening resources in all CHAM facilities.
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Summary of Study Findings
The findings of the study were:
1. The prevalence of cervical cancer screening in women living with HIV infection in HIV
support groups in Lilongwe District in Malawi was 27.8% (95% CI:22.7%, 32.9%)
2. The overall knowledge range score of the respondents was 0-31 correct answers (M =
25.63, SD = 6.35). The overall results in the table show that the respondents were
knowledgeable about cervical cancer and screening. However, the mean values and
standard deviation of knowledge of the respondents was higher in respondents who were
screened (M = 27.77, SD = 3.03) with a range of 18-31scores than those who were not
screened (M = 24.80, SD = 7.07).
3. The overall respondent‟s attitude score about cervical cancer screening ranged from 0-5
with (M = 4.12, SD = 1.33). This shows that, overall, the respondents had positive attitude
regarding screening. However, the mean values and standard deviation of respondent‟s
attitude regarding screening, was higher in women who were screened (M = 4.49, SD =
1.04) with a range of 0-5 scores than the mean knowledge of those who were not screened
3.98+1.41 (0-5).
4. The overall respondent‟s social support networks score about cervical cancer screening
ranged from 0-11 (M = 7.82, SD = 2.67). This shows that, the respondents who had social
support networks that influence screening bahavior. However, the respondent‟s social
support networks score regarding screening, was higher in women who were screened (M
= 8.93, SD = 2.21) with a range of 0-11 scores than the mean social support networks
score of those who were not screened (M = 7.40, SD = 2.71) with a range of 0-11 .
5. The overall respondent‟s score for access to screening services ranged from 3-12 (M =
10.13, SD = 1.93). However, the respondent‟s access to screening services score was
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higher in women who were screened (M = 10.84, SD = 1.98) with a range of 4-12 scores
than those who were not screened (M = 9.86. SD = 1.84) with a range of 3-12 score.
6. The factors associated with cervical cancer screening include occupation OR = 6.53 (95%
CI: 1.65, 25.90), income OR = 2.23 (95% CI: 1.1, 4.72), knowledge OR = 1.12 (95% CI:
1.05, 1.20), attitude OR = 1.45 (95% CI: 1.14, 1.84), social support network OR = 1.34
(95% CI: 1.17, 1.53), and access to health care services OR = 1.40 (95% CI: 1.17, 1.68).
7. Factors independently associated with cervical cancer screening services include
knowledge OR = 1.1 (95% CI: 1.02, 1.19) and attitude OR = 1.36 (95% CI: 1.04, 1.76
after adjusting for occupation, income, social support networks, and access to screening
services.
8. The Cronbach‟s alpha for whole instrument with 59 items and 4 subscales: knowledge
with 31 items, attitude with 5 items, social support network with 11 items, and access to
screening with 12 items was 0.88. This means that the overall instrument had good
internal consistency (reliability).
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CHAPTER 5
DISCUSSION
The discussion section of the study findings has been presented in relation to the
concepts of the situation specific concepts which include participant‟s socio-demographic
characteristics, cervical cancer screening, knowledge, attitude, social support network, and
access to screening services. During discussion, study findings have been presented first then
discussion, supported by relevant literature.
Socio-demographic Characteristics
The study sample was predominantly by women who had never attended or had
primary education (79%). This is consistent with the findings of the Malawi Demographic
and Health Survey 2015-17, which indicated that 86% of females have ever attended school
(MDHS, 2017). Additionally, this report indicated that to a majority of the women, primary
education is the highest level of schooling and only 5% have completed secondary school.
This supports the finding that the majorities (96.6%) of the participants were not working and
had low monthly income of less than 100 US dollars. Further, this supports the idea that
working is a strong factor for screening as women get paid and can afford transport to go for
screening services. Even though the screening services are free in Malawi, women who are
not working with low monthly income of less than $100 cannot afford to pay for transport to
go for screening services which are only offered in few health facilities in Malawi.
Cervical Cancer Screening
The proportion of women screened after HIV diagnosis was 27.8%. In a study
conducted by Msyamboza and colleagues (2016), the screening rate for HIV-positive women
in Malawi was 15.9%. The screening rate increased by 11.9% for HIV-positive women. This
increase might be due to the fact that women living with HIV infection are exposed to health
information during their doctor appointments to get their ART drugs in addition to nation-
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wide campaigns that call for all women to undergo screening. Despite HIV-positive women
visiting ART clinics regularly to access drugs, the screening rate for HIV positive women is
still low. This finding is in line with literature review study which was conducted in African
countries where it was found that the screening rate in HIV-positive women was also low, for
instance: Nigeria 9.4%, South Africa 22.3%, and Zimbabwe 9% (Ezechi et al., 2013; Maree
& Moitse, 2014; Matangaidze et al., 2016). There is need for health care providers to follow
up with these women during the ART appointment visits and provide them with the screening
services. Additionally, the Malawi cervical cancer screening guidelines recommend that HIVpositive women should have annual cervical screening or at least once to have baseline data
for evaluation for their follow-up annual screening for those with normal results (MOH,
2017). This indicates that there is noncompliance with cervical cancer screening guidelines
for HIV-positive women in Malawi. If Malawi is to fight cervical cancer, the guidelines must
be followed. Furthermore, the guidelines indicate that VIA targets women aged 30-45 years
(Malawi, MOH, 2017). In studies, VIA positive rate and cancer suspects have been detected
in women aged less than 30 years and above 45 (Msyamboza et el., 2016). This may be due
to high HIV-prevalence rate among women aged 15-49 years. This calls for review of
screening guidelines in the country and further research in VIA accuracy among postmenopausal women.
Additionally, 70% of the working women had been screened compared to 26.3% of
those who were not working. Working in most Malawi community means a paid up job and
not substance farming. The results indicated that 10 (3.4%) of the women were working. This
is inconsistent with the findings in Malawi demographic health survey which has indicated
that 63% of the women are working (MDHS, 2017). This may mean that 3.4% of the sample
size is not the representation of the larger population of working women in Lilongwe, Malawi
or the MDHS data is not correct as it is based on estimates.
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Knowledge Regarding Cervical Cancer and Screening
The study findings revealed that women had t knowledge regarding cervical cancer
and screening (M = 25.63, SD 6.35). This is inconsistent with previous studies conducted in
Malawi on all women that reported that women had inadequate knowledge regarding cervical
cancer signs and symptoms, risk factors, and preventive strategies (Maseko et al., 2015;
Munthali et al., 2015; Mtengezo & Lee, 2018). This finding could reflect of the impact of
health promotion messages that HIV positive women receive during their OPD appointment
visits and the ongoing mass campaign about cancer and screening services on the radio and
meetings by the First Lady and through the health talks at clinics by health care providers.
Most radio stations and television in Malawi have public service announcements where the
First Lady of Malawi campaigns for cervical cancer screening. She talks about the benefits of
screening and disadvantages of not screening. And she calls for all women to go for
screening. On the other hand, the impact of messages on the media needs to be evaluated. In
Malawi, the urban households are more likely than rural households to own a television (45%
versus 6%) and a radio (65% versus 36%) (MDHS, 2017). This may mean that those living in
urban area get the information and more likely go for screening than those living in rural
areas. On the other hand, even those living in urban areas, they may tune to other channels
and miss the information. The impact of media announcement on cervical cancer screening
uptake needs to be evaluated in both urban and rural areas.
Using logistic regression, knowledge is independently associated with screening. In
the adjusted model, it showed that with 1 unit increase in knowledge score, women are 10%
more likely to undergo cervical cancer screening services [OR = 1.10 (95% CI: 1.02, 1.19)]
but the difference was not statistically significance between the non-screened and screened
women. Both groups had high knowledge regarding cervical cancer and screening but their
cervical cancer screening uptake was still very low. This may mean that knowledge is not
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translating into practice or the respondents were answering questions in a manner that would
be viewed favorable by the researcher. This finding concurred with the study conducted in
South Africa by Maree and Meitse (2014) which found that women had knowledge regarding
cervical cancer and screening, but the screening uptake was low (22.3%). The possible reason
for not going for screening may be related to attitude, beliefs, and misinformation about
screening procedure being painful (Mtengezo & Lee, 2018).
On the other hand, even though women had high knowledge regarding cancer and
screening. On the other hand, almost half of the respondents were not aware that smoking,
having a family member diagnosed with cancer, and taking family planning pills for a long
time increases the woman‟s risk of developing cervical cancer. Previous studies in Malawi
revealed that lack of knowledge and awareness about risk factors impacted screening uptake
(Maseko et al, 2015; Munthali et al., 2015). Additionally, almost half of the respondents were
not aware that there is treatment for cervical cancer. This finding is in line with a qualitative
study done in Malawi which found that women were aware that there is no treatment for
cervical cancer (Mtengezo & Lee, 2018).
On the other hand, the current found out that 84% of the women indicated that VIA is
a means of receiving cervical cancer treatment if diagnosed early. This high knowledge may
also indicate weakness in the closed ended questions as women could just guess responses.
There is need to develop culturally targeted educational intervention programs for HIV
positive women so that women become knowledgeable regarding cervical cancer signs and
symptoms, risk factors, preventive strategies; and risks and benefits of screening.
Attitude Regarding Screening
The respondent‟s attitude score about cervical cancer screening ranged from 0-5 (M =
4.12, SD = 1.33). However, the respondent‟s attitude regarding screening, was higher in
women who were screened (M = 4.49, SD = 1.04) with a range of 0-5 scores than those who
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were not screened (M = 3.98, SD = 1.41). This finding is in line with a study conducted in
Zimbambwe where it was found that 96.2% of the women indicated that they would like to
undergo screening. However, this study identified several factors that could have prevented
them from undergoing screening. Some women indicated that they feared the procedure 54
(18.6%). Some women felt shy to expose their private parts 49 (16.8%). Some were afraid of
being diagnosed with cancer 45 (15.5%); and some were afraid of pain during the procedure
54 (18.6%). These findings are in line with studies conducted in Malawi and South Africa on
barriers to screening where women believed that cervical cancer is caused by the exposure to
the VIA process and that the procedure is painful (Maree & Moitse, 2014; Munthali et al.,
2015, Mtengezo & Lee, 2018). However, in the current study, feeling shy to expose private
parts to male service providers was not associated with screening as other studies found
(Munthali et al., 2015, Mtengezo & Lee, 2018). Respondents further indicated that they
would be comfortable to be screened by either male or female service providers. This reflects
that women view screening as a health procedure that doctors of either sex can perform.
Further, the logistic regression model showed positive association between attitude and
screening. With 1 unit increase in attitude score, women are 36% more likely to undergo
screening (OR= 1.36, 95% CI: 1.04-1.76). These results indicate that there is need for
continued efforts to address women‟s attitude to promote screening uptake.
Social Support Networks
In simple logistic regression, the results indicate that the odds for screening were
associated with social support networks (OR = 1.16, 95% CI: 1.01-1.34). In multivariate
logistic regression, the odds of screening lost significance. Therefore, social support network
in not independently associated with screening. It means that the variable exists but its
influence on screening could not be directly detected in this study. Studies have indicated that
friends offer information and advice relating to behavior change (Wigfall et al., 2015). The
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reasons for protective effects of social support networks and income on screening needs to be
further studied. The possible reasons would be that the instrument measured only positive
dimensions of social support networks in influencing behavior change rather than the
negative aspects of network like stigma. Only one-fifth (22.7%) of the participants indicated
that family members tried to help them with financial support, and 54% of the women got
emotional support from family members. The next study should consider measuring the
negative dimension of social support network like exploring and understanding the meaning
and lived experiences of stigma among women or individuals living with HIV/AIDS and
their family members in Malawi. Understanding the negative aspect is critical for improving
screening uptake and compliance.
Access to Screening Services
Only 96 (33%) of the women indicated that they received screening the first time they
needed it from Government and Non-Governmental (CHAM and private) health facilities.
The WHO indicated that access is related to affordability, availability, accommodation,
accessibility, and acceptability (WHO, 2002). In terms of affordability, there are no user fees
to access cervical cancer services in public and private-not-for-profit health facilities in
Malawi, but the screening sites are far. This indicates that screening services are not
integrated into HIV services. All HIV-positive women access the ART clinics for their
treatment monthly or every three months in health facilities. If the services were integrated, it
would lessen frequent hospital visits for preventive services as most women travel long
distance to access screening services. The findings indicated that the majority, 239 (82.1%) of
the respondents took more than 30 minutes to go to a health care facility. When women were
asked if they travel less than or more than 30 minutes, most women reported more than an
hour. This means that in the next study, the measure should be one hour as 30 minutes is
considered as a short distance. This is in line with a case study report conducted in Malawi on
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a woman who travelled 60 km for the whole day for post-VIA treatment at another facility
(Lee et al., 2015). This means that women in rural areas cannot afford transport money. In
this study, women could not afford transport money 116 (39.9%) to go for screening when
they already had a hospital visit. On the other hand, there are screening sites in CHAM
facilities close to them and they charge a small service fee like one dollar (Maseko et al.,
2015; Munthali et al., 2015). But the women think this is payment for the services and they
prefer to go to public health facilities and may pay as much as two dollars for transport
(Mtengezo & Lee, 2018). This shows that screening services are not yet integrated with the
ART services to prevent frequent hospital visits and to different facilities.
In terms of availability, the majority of the women (82%) reported that they travel
more than 30 minutes to screening sites and they wait for a long time to be screened. These
findings are in line with the study done in Malawi that showed that there were only 130
screening sites in the country (Msyamboza et al., 2015) and the women were dissatisfied with
screening services in Malawi due to distance and waiting time (Maseko et al., 2014). In
logistic regression, it showed that with 1 unit increase in access to screening services, women
are 25% more likely to go for screening [OR = 1.25 (95% CI: 1.05, 1.48)]. This is in line with
a qualitative study finding as respondents suggested that to increase access to screening
services, there was need to integrate screening services with ART services so that women are
screened as they start ART as part of comprehensive physical assessment and baseline data
(Mtengezo & Lee, 2018). Unfortunately, the services are not integrated; therefore, women are
unlikely to travel to the clinic just for screening if they are not having signs and symptoms of
cancer. This may be a possible reason that women visit the clinic when they have signs and
symptoms of cancer (Msyamboza et al., 2016). A possible explanation for this is that the
majority of the women (96.6%) are not working and 88.7% of the women have a monthly
income less than $100. They might not be in a position to have sufficient financial resources
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to go for preventive services when they are not sick. The Sustainable Development Goal
(SDG) number 3 promises to “ensure healthy lives and promote well-being for all at all
ages”. Specifically goal 3.4 which emphasize “reducing premature mortality from noncommunicable diseases (NCDs)” and goal 3.7 which stipulates “ensuring universal access to
sexual and reproductive health care services” (https://sustainabledevelopment.un.org/sdgs).
As stipulated in a qualitative study, there is need to have targeted follow up screening dates
together with ART visits (Mtengezo & Lee, 2018). Health care providers should check and
remind the women on follow up screening dated at every hospital appointment visit. There is
evidence in Kenya that showed that with targeted interventions for HIV-positive women, the
screening rate was as high as 84% (Rosser et al., 2015). If we are to promote healthy lives of
women with low income and living with HIV infection, opportunistic screening in the
community and in health facilities should be encouraged to improve screening uptake. This
calls for review of sexual and reproductive health and ART policies to deal with cervical
cancer screening and follow-ups in all ART sites, health facilities and in the community.
In terms of accommodation, the study found that there were no equipment and the
service providers were inadequate in most clinics where women visit for ART drug supply.
The clinics could not accommodate women if they needed screening due to lack of trained
health care providers and equipment. This is in line with a study done on health systems
challenges in cervical cancer prevention program in Malawi. The study found that 52% of the
facilities reported stock outs of supplies and in some facilities, women contributed money to
buy acetic acid (Maseko et al, 2015). Additionally, the cervical cancer screening guidelines
stipulate that the cervical cancer screening providers must be certified to conduct screening
and treatment activities. There are only 272 active service providers in Malawi (MOH, 2017).
The number of providers is inadequate, and not all preventive services might be provided.
There is a shortage of health personnel and these same providers are also providing curative
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and other services. The shortage of health workers is worse in rural areas than in urban areas
and this might contribute to low screening rate (22.4%) in rural compared in urban (31.4%)
areas. This calls for training all ART providers on VIA. The VIA is the recommended
approach for cervical cancer screening by CDC for developing countries where there are
resource constraints (CDC, 2013). On the other hand, almost all women (99%) had cervical
cancer screening in either Government or CHAM facilities. In most of the Government or
CHAM health facilities in Malawi, there is inadequate budgetary allocation which results in
frequent stock outs of supplies for cervical screening like vinegar, speculums, cryotherapy
unit, CO2 cylinders, thermos-coagulators, and infection prevention supplies (Msiyamboza et
al., 2016). With all these challenges facing Malawi health care including the new cervical
cancer guideline to extend the screening interval for HIV-positive women from one to three
years (MOH, 2017) is counter-productive given the higher risk for cervical cancer among
women living with HIV infection. Considering the HIV prevalence in the country, annual
screening remains the recommended interval for women living with HIV infection. In the
United States, to ensure that cervical cancer prevention remains a priority in HIV positive
women, refined screening criteria such that HIV positive women undergo three consecutive
annual screening. If women have normal Pap tests in three consecutive annual screening,
thereafter, follow-up is recommended every three years (HIV/AIDS Treatment Guidelines,
2015).
In terms of acceptability, few women did not see the reason to go for screening
because they thought that they were not sick. Others stated that they were too old and feared
male service providers. This is in line with a qualitative study conducted by the researcher in
Malawi on perceptions of women on screening. Women indicated that they did not see the
reason for screening as they were either old or were already HIV positive, and others feared
male service providers. These results indicate a need to address issues relating to
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acceptability in preventive sexual and reproductive health services in elderly women and
HIV-positive women on the benefits of screening and the disease process.
Reliability of the Measurement
The instrument was developed based on literature review and qualitative pilot study.
The instrument covered the demographic characteristics and the five major concepts of the
study: Knowledge, attitude, social support network, and access to screening services
Knowledge had 31 items with 4 subscales. The subscales included knowledge regarding risk
factors of cervical cancer with 13 items and the Cronbach alpha was 0.87. Knowledge
regarding signs and symptoms of cervical cancer with 11 items and the internal consistency
for knowledge subscale had a Cronbach alpha of 0.90. Knowledge regarding prevention
strategies of cervical cancer with 4 items and the internal consistency was not computed as it
had few (4) questions. Awareness of cervical cancer, screening, and HIV/AIDS with 3 items
and the internal consistency of the awareness sub-scale were not computed as it had few
questions. Attitude regarding cervical cancer screening had 5 items and the internal
consistency for attitude subscale had Cronbach alpha of 0.74. Social support network
regarding cervical cancer screening had 11 items and the internal consistency for social
support network had a Cronbach alpha of 0.81. Access to cervical cancer screening services
had 12 items and the internal consistency for access to screening services had a Cronbach
alpha of 0.88. The overall instrument had 59 items and the internal consistency for the
overall instrument had a Cronbach alpha of 0.88. This means that the overall instrument had
satisfactory internal consistency (reliability).
Summary of Discussion
This was the first empirical study to examine the prevalence of cervical cancer
screening, the level of knowledge and attitude regarding cervical cancer and screening in
Malawi; and to determine factors associated with screening behavior among Malawian HIV
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positive women in Malawi. The prevalence of cervical cancer screening in women living with
HIV infection in HIV support groups in Lilongwe District in Malawi was still low. In
general, both women, those who received screening and women who were not screened had
high knowledge regarding cervical cancer and screening. But women who were screened, had
higher knowledge score (M = 27.77, SD = 3.03) compared to those who were not screened (M
= 24.80, SD = 7.07) even though the difference was not statistically significant.
The respondents had a positive attitude regarding screening. The respondent‟s attitude
regarding screening, was higher in women who were screened (M = 4.49, SD = 1.04) than
those who were not screened (M =3.98. SD = 1.41). This could be, the questions about VIA
was asked to all women who were exposed to VIA procedure or not exposed. However, the
majority were willing to be screened.
The respondents had social support networks that influence screening bahavior.
However, the mean values and standard deviation of respondent‟s social support networks
score regarding screening, was higher in women who were screened (M = 8.93, SD = 2.21)
with a range of 0-11 scores than those who were not screened (M = 7.40, SD = 2.7) . The
respondents had access to screening services. However, the respondent‟s access to screening
services score was higher in women who were screened (M = 10.84, SD 1.98) with a range of
4-12 scores than those who were not screened (M = 9.86, SD 1.84). The factors independently
associated with cervical cancer screening services include occupation OR = 5.12 (95% CI:
1.07, 24.43), knowledge OR = 1.1 (95% CI: 1.02, 1.19), attitude OR = 1.36 (95% CI: 1.04,
1.76), and access to screening services OR = 1.21 (95% CI: 1.01, 1.44). Respondents further
suggested that efforts to promote screening uptake should focus on offering screening
services in HIV support groups or within their communities, and to continue educating
women on the benefits of screening. The Cronbach‟s alpha for whole instrument with 59
items and 4 subscales: knowledge with 31 items, attitude with 5 items, social support network
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with 11 items, and access to screening with 12 items was 0.88. This means that the overall
instrument was reliable to be used for women living with HIV infection in support groups.
Study Limitations
The study had methodological limitations which include: 1) The study focused on
women enrolled in HIV support groups. This means that women were exposed to health
information messages hence increased knowledge regarding cervical cancer and screening,
Additionaaly, the sample may not be representative of all HIV positive women in Malawi, as
a result, the findings cannot be generalised to all HIV positive women in Malawi. 2) For
those women who were screened, there was limited data on what or who influenced them to
undergo screening, family stigma and the role of spouses in screening was not investigated.
3) Descriptive correlational design creates a snapshot and results cannot be used to draw
inferences about causal relationships between and among the variables. 4) Self-reports studies
creates response bias. 5) The study instrument was developed based on literature review and
qualitative study. The study adapted the demographic measures used in literature like
occupation and income which is measured differently within Malawian cobtext. In malawi,
occupation means paid job and income is measured by comodities that a person has like
cattle, goats, bicycle and so on. Since the instrument was purpose designed, therefore, there is
need to validate the tool in a larger sample.
Recommendations
The Malawi Ministry of Health vision is “Malawian women free from cervical
cancer” and a screening coverage rate of 80% for all women aged 25-49 years…”. If this
dream is to be realized, there is need to have synergetic efforts at a policy level, health
facilities, nursing education and research.
Policy level. The policy level should ensure that adequate resources for cervical
cancer prevention and control activities are available in all health facilities in the country.
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The ART and SRH policies should be reviewed to facilitate universal and multiple access to
screening services. Before introduction of ART, there should be a routine of cervical cancer
screening among HIV positive women.
Health facilities. The health facilities as implementing agents for HIV and screening
should integrate screening services into ART/HIV care and in HIV/AIDS programing
activities. The health facilities incharges should budget for the procurement of screening
supplies, and integrate the delivery of the supplies for VIA with monthly delivery of other
drugs to all health facilities. There is need to promote screening services in the community by
improving health posts to provide screening services. The health facilities should train more
cervical cancer service providers. Community advocacy and awareness on the benefits of
screening and the disease process should be increased by using existing Village Health
Committee and Community Health Action Groups.
Nursing education. The training institutions should review pre-service curricula and
incoorporate cervical cancer screening core competencies in nursing and medical curricula.
Future research.
The study targeted only women living with HIV infection in support groups, there is
need to have a comparison study for three groups: women living with HIV infection not in
support groups, those in support groups, and HIV negative women. Since the instrument was
purpose designed, there is need to validate the instrument and to test hypothesis (theory) in a
larger sample. There is need to conduct a study on the role of social support networks
(including spouces) in influencing screening behavior. Lastly, the negative dimension of
social support network like family stigma regarding screening should further be explored.
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Conclusion
Cervical cancer is a preventable and curable disease when detected early through
screening. Despite frequent visits to ART clinics, having knowledge and positive attitude
regarding screening among HIV-positive women, screening rates remained low. This means
that knowledge and a positive attitude regarding screening did not translate into practice.
Efforts to ensure timely screening among HIV positive women may require communitybased intervention such as health education messages regarding disease processes, risk
factors, and benefits of screening and to promote screening uptakes in women living with
HIV infection in Malawi.
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B. FLOW DIAGRAM
Peer reviewed literature search

Identification

Gray literature search

Articles identified through
website and conference
abstract searches (N= 3)

Citations retrieved through
database searches
(N =23)

Articles not directly
investing Cervical
Cancer Screening= 2

Screening

Records screened
(N=21)

Articles excluded as
duplicates =2

Eligibility

Full text articles assessed for
eligibility
(N= 19)

Full text articles
excluded (N=2)
-Did not focus on
women

Included

Studies included
(N=17)

Studies
included
(N=3)

Total studies included (N =20)
Malawi= 8
Sub-Saharan Africa= 6
Developed Countries= 6
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C. EVIDENCE TABLE FOR CERVICAL CANCER SCREENING.
Author

1 Chadza,
2012

2 Chidyao
ngaMaseko
et al.,
2015

3 Fort et
al., 2011

Purpose

Design and
place

Screen
ing
rate
and
Test
VIA

Knowledge

To
explore
factors,
those
contribut
e to
delay in
seeking
early
diagnosis
and
treatment
of
cervical
cancer
among
women
in
Malawi.
To
identify
barriers
to
utilizatio
n of
cervical
cancer
preventio
n
services
in low
and
middleincome
countries
Investiga
ted how
women
in rural
Malawi
make
healthseeking
decisions
regarding
cervical
cancer
screening

Qualitative
-In-depth
interviews
using a
semistructured
interview
guide (24
women -25
- 60 years)
diagnosed
with
cervical
cancer)

Attitude

Document
review

VIA

Lack of
awareness,
and
knowledge:
-Risk factors
- Prevention
of cancer

Stigma in
discussin
g
reproduct
ive
health
issues

Qualitative
study-indepth
interviews.
Used semistructured
interview
guide (20
Women in
two sites of
rural
Malawi -10
each site,
aged 20 50)

VIA

Facilitators
:
-Having
symptoms of
cervical
cancer.
Barriers:
-Low
knowledge
levels

Barriers
:
-Low
perceive
d
susceptib
ility
-Low
perceive
d
benefits
from the
service.

Limited
knowledge
on:
-Symptoms
and signs of
cancer
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Social
Influe
nce

Access to
health care

Limited
accessibility:
-Unavailability
of cancer
screening
facilities
-Financial
resources for
transport

4 Lee et
al.,
(2015)

5 Maseko
et al.,
2015

6 Maseko
et al.,
2014

To
highlight
the
difficulti
es at a
grassroot
s level of
obtaining
appropria
te
treatment
Explorin
g health
system
gaps
responsib
le for the
poor
performa
nce of
the
cervical
cancer
preventio
n
program
in
Malawi.

To assess
client
satisfacti
on
among
women
who had
been
screened
for
cervical
cancer

Qualitative
study-case
study (25
years, HIV
negative
woman
who was
detected
with a precancerous)

VIA

lack of access
to screening
and treatment
due to
socioeconomic
problems
-Unavailability
of services

Mixed
methods
crosssectional
quantitative
and
qualitative
approachsurvey Checklist Interview
guide (14
districts.
Service
providers41 service
providers
from 21
health
facilities
and nine
district
coordinator
s)
Cross
sectional
study and
quantitative
approaches
(120
women
mean age
of 33.7
(SD=10.1)
who were
screened
for cervical
cancer)

VIA

-Inadequate
service
providers who
are poorly
supervised;
-lack of basic
equipment and
stock-outs of
basic medical
supplies
-inadequate
funding of the
program

VIA

Satisfaction
was
predicted by
having
previous
knowledge
of the
- VIA test,
K
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Satisfaction
was predicted
by:
- having an
appointment
before the
screening with
adjusted odd
ratio of
5.71(95% CI:
1.75. 18.63),
-distance from
the home to
the health
facility
AOR = 0.11
(95% CI: 0.02,
0.65)
-Waiting time
AOR = 0.09
(95% CI: 0.09,
0.83).

7 Munthali
et al.,
2015

8 Msyamb
oza et al.,
(2016)

To assess
service
provider'
s
perceptio
ns about
women‟s
barriers
to
cervical
cancer
screening
and
treatment
To
evaluate
the
uptake
and
challenge
s of
screening
services
by age,
HIV
serostatus
and
trends
over a
five-year
period
(2011–
2015) in
Malawi.

Qualitative
- in-depth
interviews
(13 district
coordinator
s and 40
Service
Providers
service
providers
of cervical
cancer
screening)

VIA

Program
data
analysis
(2011–
2015). 28.1
% were
aged 29 or
less, 56.1
%) were
between
30–45, and
15.8 %
were 46
years or
more

26.5%
(HIV+
and women
.
15.9%
HIV+
women
. -VIA

Lack of
awareness of
the disease

Misconc
eptions
about the
disease
that it is
caused
by
exposure
to the
VIA
process

Lack
of
involv
ement
of
husban
ds,

-Shortage of
staff,
-lack of
equipment
and supplies,
-lack of
supervision,
-use of male
service
providers,
-long distance,

Failure to treat
VIA positive
women
eligible for
cryotherapy
due to stock
out of gas,
faulty/broken
cryotherapy
machine or no
cryotherapy
machine.
-For cancer
suspect, lack
of
loop
electrosurgical
excision
procedure
(LEEP)
machine or
inadequate
gynecologists
at the referral
center. Cancer
radiotherapy
services were
not available.

Evidence Table for cervical cancer screening in HIV positive women African countries
Author

1 Ezechi,
GabOkafor,
Ostergr
en, &
Odberg
Petterss
on,
(2013)

Purpose

Design and
place

To assess
the
willingnes
s and
acceptabil
ity of
cervical
cancer
screening

Crosssectional
study in
Nigeria
(1517 HIV
positive
women)

Screen
ing
rate
and
Test
9.4%.
Pap
Smears

Knowledge

Attitude

56.2% were
aware of
cervical
cancer

79.8%
accepted
to take
the test
in the
future
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Social
Influe
nce

Access to
health care

Barriers: Cost
of the test
Religious
denial.
Facilitators:
Tertiary
education
level, aware of
cervical

2 Maree
&
Moitse,
(2014).

3 Matang
aidze et
al.,
(2016)

4 Rositch
et al.,
(2012)

among
HIV
positive
Nigerian
women
To
determine
what
women
being
treated for
HIV and
AIDS in
South
Africa
knew
about
cervical
cancer and
cervical
screening
To
determine
the
knowledg
e, attitude
and
practices
of HIV
infected
women on
cervical
cancer and
cervical
cancer
screening
in
Zimbabwe
.
To assess
adult
women‟s
knowledg
e of
human
papilloma
virus
(HPV)
and
cervical
cancer,
and
characteri
ze their
attitudes
towards
potential
screening
and
prevention

cancer, no
living child,
recent HIV
diagnosis
Crosssectional
study in
South
Africa
(315 HIV
positive
women)

22.3%.
Pap
Smears

78.7% had
heard of
cervical
cancer,
62.9% knew
about the
Pap smear,

Fear the
procedur
e.

Mixed
methods -A
cross
sectional
survey and
qualitative
in
Zimbabwe
(208 HIV
positive
women)

9%.
VIA

21.6% knew
cervical
cancer
disease.
-55.3%
knew that
cervical
cancer is
preventable.
-92.8% did
not know
screening
tests

77.4%
felt at
risk of
cervical
cancer.
-96.2%
reported
they
would
like to
undergo
screening
in the
future.

Cross
sectional
study- Preand post in
Kenya
(409: 268
HIV
positive
and 141
HIV
negative
women
median age
29 years

67% of
HIV
positiv
e
women
. Pap
Smears

18% had
ever heard
of HPV
-69% new
that Pap
smears
detect
cervical
cancer.
-18% knew
that routine
Pap
screening is
the main
way to
prevent it

Most
women
reported:
-high
level of
cultural
acceptabi
lity for
screening
- low
level of
discomfo
rt during
Pap
smear
collectio
n
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Social
netwo
rk:
Source
of
inform
ation:
Health
care
worker
s

-Over 80% of
women
reported that
they would
feel
comfortable
using a selfsampling
device
-82% would
prefer at-home
sample
collection

strategies

5 Rosser
et al.,
(2015)

6 Wake et
al.,
(2009)

To assess
cervical
cancer
knowledg
e,
personal
risk,
perception
, stigma,
and
screening
uptake
among
women
enrolled in
the HIV
Study
clinic in
Kenya
To
ascertain
the
perception
of cervical
screening
practices
among
HIVpositive
women
attending
an ART
clinic in
urban
South
Africa

Crosssectional
study in
Kenya
(106 HIV
positive
women)

84%.
VIA

99% had
heard of
screening.

-70% felt
at risk.
- Feeling
at risk
and
screening
. was
associate
d with
duration
of HIV
diagnosis

Mixed
methodsprospective
crosssectional
study and
Qualitative
study in
South
Africa
(113 HIV
positive
women
aged 21-64:
randomly
selected
from the
register)

59%.
Pap
Smears

-78% had
never heard
of cervical
cancer.
-40% had no
correct
knowledge
about
screening

-84.95 %
expresse
d the
desire to
undergo
screening
in the
future.
-15% had
fear and
misunder
standing
on
screening

48% would not
get screened if
they had to
pay for it

Reason
s for
not
screeni
ng
include
they
had
never
been
asked
to.

The time or
place
of the test
meant that
they were
unable to
attend.

Evidence Table for cervical cancer screening in HIV positive women in other
developed
countries.
Author

Purpose

Design and
place

Screen
ing
rate
and
Test

Knowledge
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Attitude

Social
Influe
nce

Access to
health care

1 Bynum,
et al.,
(2013)

2 Dal
Maso et
al.,
(2010)

3 Leece,
Kendall,
Touchie
, Pottie,
Angel,
&
Jaffey,
(2010)

To assess
the
influence
of health
literacy on
women
living
with HIV
cervical
cancer
screening
knowledg
e and
behaviors
in the
southeaste
rn USA.
To
evaluate
the history
of Papsmear in
HIVpositive
women
and to
examine
the sociodemograp
hic,
clinical,
and
organizati
onal
factors
associated
with
adherence
to cervical
cancer
screening
in Italy.
To
determine
the rate of
cervical
screening
among
HIVpositive
women,
and to
determine
whether
screening
rates were
influenced
by having
a primary
care

Crosssectional
study (145
HIV
positive
women) in
USA

Pap
Smears

No
difference in
cervical
cancer or
HPV
knowledge
among those
with low
versus high
health
literacy.

Cross
sectional
study (1002
HIV
positive
women.
Median age
41 years in
Italy.

90.9%.
Pap
Smears

Lack of
knowledge
on follow-up
care.

Retrospecti
ve Chart
review
(218
women) in
Canada

58%.
Pap
smears
and
cytolo
gy

-Noncomplian
ce to
cervical
cancer
screening
protocol
due to
low CD4
count

Social
netwo
rkbetter
screeni
ng
partici
pation
was
associa
ted
with
getting
advice
from
gyneco
logist

Difficulties in
following the
recommended
protocol of
combining
routine followup of HIV
infection with
gynecological
examination

-Women with
insurance
coverage and
with
gynecological
visits were
more likely to
receive
screening
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provider.
4 Sichanh
, 2014

To
determine
the
knowledg
e,
awareness
and
attitudes
about
cervical
cancer
among
Lao
women
attending
or not an
HIV
treatment
center

5 Wigfall
et al.,
(2015)

To
examine
associatio
ns
between
WLHA‟s
cervical
cancer
prevention
knowledg
e and
abnormal
Pap test
history in
USA

6 William
s et al.,
(2015

To
examine
sociocultu
ral and
structural
factors
associated
with
cervical
cancer
screening
among
HIV-

A crosssectional
case–
control (32
0 women
aged 25 to
65, living
with HIV –
Controls
were 320
women
matched
for age and
place of
residence,
not
attending
an HIV
treatment
center) in
Asia
Crosssectional
study (106
urban and
rural
WLHA
from Ryan
Whitefunded
clinics and
AIDS
service
organizatio
ns. Mean
age
46.3±10.9
in the
SouthEastern
USA.

3.9%.
Pap
Smears

Reasons for
not
screening
include:
-the absence
of symptoms
-lack of
information
and
ignorance of
screening
usefulness

Social
netwo
rk:
Source
of
inform
ation:
Health
care
profess
ionals

83%.
Pap
Smears

-84 % knew
that WLHA
should have
a Pap test
every year.
- Women
who had an
abnormal
Pap test
knew
follow-up
care.

Social
netwo
rks:
Those
who
had
friends
with
an
abnor
mal
Pap
test,
knew
the
screeni
ng
period
for
HIV
positiv
e
women
yearly.

Qualitative
study- indepth
interviews
(20
AfricanAmerican
women)
in USA

Pap
Smears

Lack of
knowledge
about
cervical
cancer and
screening,
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Lack of
perceive
d
susceptib
ility to
cervical
cancer

infected
African
American
in
Alabama
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D. CONCEPTUAL-THEORETICAL-EMPIRICAL STRUCTURE
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E. RESEARCH ASSISTANTS TRAINING PROGRAM PLAN
Day 1
Time
8.00-10.00 am

Responsible person
Mtengezo

10.00-10.15 am

Activity
Study overview: Objectives, Confidentiality and IRB,
survey consent form
Tea Break

10.15- 12.00 pm

Review of survey instrument by RA and content experts

Mtengezo
Dr. MarySue Makin

12.00- 1.00 pm

Lunch

1.00- 2.00 pm

Cognitive interviews by conducting FGD with 5 HIV
positive women

Mtengezo

3.00- 4.00 pm

Debriefing

Mtengezo
Dr. MarySue Makin

4.00- 4.15 pm

Tea Break

4.15- 4.30 pm

Making corrections on the survey instrument

Time
8.00-10.00 am

Activity
Recap

10.00-10.15 am

Tea Break

10.15- 12.30 pm

RAs

12.30- 1.30 pm

Survey administration practice and pretesting the
instrument to 5 HIV positive women
Lunch

1.30- 2.30 pm

Report observation on the survey instrument

RAs

2.30 pm

Close

2.30- 5.00

The researcher makes corrections and prints copies of the
survey instrument

Mtengezo

Day 2
Responsible person
Mtengezo
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Mtengezo

F. INFORMED VOLUNTARY CONSENT FORMS
English
University of Massachusetts, Boston
Department of Nursing
100 Morrissey Boulevard Boston, MA. 02125-3393

Daeyang Luke Hospital
P.O. Box 30330
Lilongwe

Please read this form and feel free to ask questions.
Study Title: Knowledge and Attitudes Regarding Cervical Cancer Screening among
Women Living with HIV/AIDS in Malawi: A Cross-sectional Study
Principal Investigator: Jasintha Mtengezo, PhD candidate
Supervisors: Haeok Lee, RN, PhD, Professor: University of Massachusetts Boston
Mary Cooley, RN, PhD, Professor: University of Massachusetts Boston
Ling Shi, Bio-Statistician, PhD, Professor: University of Massachusetts Boston
MarySue Makin, MD, Obstetrician/Gynecologist: Daeyang Luke Hospital
Description of the Project
You are asked to take part in a research project to explore your views about cervical
examination to detect cervical cancer in women who are living with HIV infection. The study
will help to develop ways of promoting cervical cancer examination program for women who
are living with HIV infection to prevent cervical cancer and live a quality life.
What will happen if you join the study?
If you agree to take part in this study, you will be asked to answer the health survey
questions about yourself, your knowledge and attitudes regarding cervical cancer and
screening, your social support networks, and access to cervical cancer screening services and
verify your cervical cancer screening status. Responding to the questions will take
approximately 30 to 45 minutes and will be done at your support group meeting place and
using your preferred language.
Risks and Discomfort
The primary risks associated with this study are that some questions may be
discomforting to you or that answering questions may make you tired. You may refuse to
answer any questions or stop at any time due to discomfort, fatigue or distress.
Benefits
There are no direct medical benefits in participating in this study but the results from
the study will help to develop ways of promoting cervical cancer examination programs
among HIV-positive women to prevent cervical cancer so that HIV-positive women live
more productive life.
Confidentiality and Anonymity:
Your part in this research is confidential. That is, the information gathered for this
project will not be published or presented in a way that would allow anyone to identify you.
You will be identified by a number code. A record of your data will be kept in a locked
cabinet in the researcher‟s office and only the research team will have access to the data. The
computer information will be protected by providing a code number and password only to the
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research team and research assistant who will enter information into the computer. All printed
materials will be stored by Ms. Mtengezo for a period of five years and then destroyed.
Voluntary Participation:
The decision to take part in this research study is voluntary. If you do decide to take
part in this study, you may stop participation at any time without any fear of any kind of
penalty. If you wish to stop participation, you should let the interviewer know immediately.
The decision to participate or not participate in this study will not affect your health care
services.
Rights:
You have the right to ask questions about this research before you sign this form and at
any time during the interview and study. You can reach Ms. Mtengezo by telephone at 01711-361. If you have any questions or concerns about your rights as a research participant,
please contact:
1. The National Health Sciences Research Committee (NHSRC), Ministry of Health,
P.O. Box 30377, Lilongwe 3. Telephone: +265 1-726 422/418 (Malawi). Email:
mohdoccentre@gmail.com
2. The University of Massachusetts Boston, Quinn Administration Building-2-080, 100
Morrissey Boulevard, Boston, MA 02125-3393. Telephone: 617-287-5370 (U.S.A).
Study Consent Form
I have read the study information sheet. My questions have been answered. My
signature on this form indicates that I understand the information and I consent to participate
in this study and for the researcher to use my information in the presentations and written
products as an aggregate data.
........................................
............................................
…………………….. ____________________
______________________
_________________
Printed Name
Signature of Participant
Date
........................................
............................................
…………………….. ____________________
______________________
_________________
Printed Name
Signature of Researcher
Date
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Chichewa
Ndondomeko ya kafukufuku ndi Pepala lopempha chilolezo mutauzidwa ndondomeko
yonse bwino bwino
University of Massachusetts Boston
Nursing
Department of Nursing
100 Morrissey Boulevard Boston, MA. 02125-3393

Daeyang College of
P.O. Box 30330
Lilongwe

Chonde werengani pepalali bwino bwino ndipo muli omasuka kufusa.
Mutu wakafukufukuyu: Kafukufuku ofuna kumva maganizo kwa amayi amene ali ndi
kachilombo ka HIV pakhani yogwiritsa ntchito chithandizo choyezetsa khansa
yakhomo la chibelekelo kuno ku Malawi.
Kafukufukuyi akupangidwa ndi: Jasintha Mtengezo- Amene akupanga maphunziro
aukachenjede ku dziko la Amereka.
Woyang’anira: Haeok Lee, Mary Cooley, ndi Ling Shi: Aphunzitsi aku sukulu ya
ukachenjede
ku dziko la Amereka.
Dokotala wamukulu amenene amathandiza azimayi kuchipatala cha
Daeyang.
MarySue Makin.
Ndondomeko ya ntchito
Mukupemphedwa kutenga nawo mbali pa kafukufuku wofuna kudziwa zomwe mukudziwapo
ndi chilingaliro chogwiritsa ntchito chithandizo choyezetsa khansa yakhomo la chibelekelo.
Kafukufukuyi anthandiza kupititsa patsogolo mwayi wa amayi amene ali ndi kachilombo ka
HIV kuti aziyezetsa komaso kuti chisamaliro chimenene chimaperekedwa kwa amayi amene
ali ndi kachilombo ka HIV chithe kuchepetsa imfa zobwera kuzera mu matenda a khansa
yakhomo la chibelekelo.
Kodi chidzachitike ndi chani ngati mungatenge nawo mbali mu kafukufukuyu?
Ngati muvomere kutenga nawo mbali mu kafukufukuyu, mudzapemphedwa kuti muyankhe
mafuso pa zomwe mukuziwapo za khansa yakhomo la chibelekelo komaso za chilingaliro
chanu chogwiritsa ntchito chithandizo choyezetsa khansa yakhomo la chibelekelo. Izi
zidzatenga pakatikakti pa mphindi makhumi atatu (30) ndi makumi anayi ndi asanu (45)
ndipo kudzachitikira komwe mumakumana pa gulu lanu komanso mchilankhulo chomwe
mungakonde.
Zodandaulitsa ndi zoopsa
Zodandaulitsa ndi zoopsa za kafukufukuyu ndi zoti, mafunso ena akhoza kukhala
osasangalatsa komanso kuyankha mafunso kukhoza kutopetsa. Mukhoza kukana kuyankha
mafunso kapena kusiya nthawi ina iliyonse ngati inu kapena ofunsa siali omasuka, kapena
mwatopa kapena mwapanikizika.
Ndiphindu lanji limene ndigapedze pakafukufuku ameneyu
Palibe chimene ndingapeze panopa pa kafukufukuyi. Koma anthandiza kupititsa patsogolo
mwayi wa amayi amene ali ndi kachilombo ka HIV kuti aziyezetsa komaso kuti chisamaliro
102

chimenene chimaperekedwa chithe kuchepetsa matenda a khasa komaso imfa zobwera kuzera
mu matenda a khansa yakhomo la chibelekelo.
Chinsinsi cha kafukufukuyu
Mbali yanu mu kafukufukuyu ndi ya chinsinsi; izi zikusonyeza kuti, china chilichonse
mutatiuze mu kafukufukuyu sichidzaulutsidwa kapena kuonetsedwa mu njira yoti anthu atha
kukuzindikirani. Mbali yanu idzadziwika kudzera mu ma nambala.
Kudzipereka pa kutenga mbali
Chiganizo chotenga nawo mbali kapena ayi pa kafukufukuyu ndi chosakakamiza. Ngati
mungafune kusiya kutenga nawo mbali pa kafukufukuyu, mutha kusiya nthawi ina iliyonse
mopanda mantha. Ngati mwafuna kusiya kutenga nawo mbali mu kafukufukuyu,
mudziwitseni amene akupatsani mafunsowa kapena amene akukufunsani mafunso. Chiganizo
chotenga nawo mbali kapena ayi mu kafukufukuyu sichisokoneza chisamaliro chanu ndi
achipatala.
Ufulu
Muli ndi ufulu ofusa mafuso okhudzana ndikafukufukuyu musanasayinire pepalali komaso
nthawi ina iliyose mkatikati mwakafukufukuyu. Mukhoza kulankhura ndi mayi Mtengezo pa
nambala ya lamya iyi 01 711 361. Ngati muli ndi fuso lina lilirose kapena madandaulo
okhudza ufulu wanu ngati munthu otenga nawo mbali pakafukufukuyu, chonde yankhurani
ndi oyimirira:
1. National Health Sciences Research Committee (NHSRC), Ministry of Health, P.O.
Box 30377, Lilongwe 3, Malawi. Pa nambalayi: +265 1-726 422/418 (Malawi).
Email: mohdoccentre@gmail.com
2. University of Massachusetts Boston, 100 Morrissey Boulevard, Boston, Quinn
Administration Building-2-080, MA 02125-3393. U.S.A. Pa nambalayi: 617-2875370.
Pepala lopempha chilolezo
Ndawerenga pepalali bwino lomwe. Mafuso anga ayankhidwa. Kusayina kwanga
kukusonyeza kuti ndavetsetsa zose zomwe zakambidwa mu pepalali ndipo ndikulola kutenga
nawo mbali mu kafukufukuyu. Komaso pakusayinira chikalatachi ndavomera kuti
zolembedwazo zikagwiritsiddwe ntchito poulutsa zotsatira zakafukufukuyu.
........................................
............................................
…………………….. ____________________
______________________
_________________
Dzina
Kusayinira kwa oyankha mafuso
Tsiku
........................................
............................................
…………………….. ____________________
______________________
_________________
Dzina
Kusayinira kwa ofufuza
Tsiku
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G. QUESTIONNAIRES
English
Knowledge and Attitudes Regarding Cervical Cancer Screening among Women Living
with HIV/AIDS in Malawi

Time at beginning of interview: [___][___] [___][___] AM / PM
Date……………………………
Hour
Minutes

Code Number: E

.

Name of Support Group: …………………………………………………

Geographical Location:

Urban …………………. 1
Rural …………………. 2
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I would like to ask you some questions to help us analyze the data. Your responses to these
questions will remain confidential, and be used for research purposes only.
Part 1: Socio-demographic Information
Q1. What is your occupation?
House wife … ......................................................1
Working (write your work) ................................2
Don‟t know/not sure .........................................88
Q2. What is your religion?
Christian ..............................................................1
Moslem ...... .........................................................2
Others (Indicate) ...... ...........................................3
Don‟t know/not sure ........................................88
Q3. How old are you?

Years
Don‟t know/not sure .........................................88

Q4. What is your marital status?
Single ...........................................1
Married.........................................2
Divorced/widowed .......................3
Other ..........................................66
........................................................................
Q5. What is your highest education level you attained?
Never attended school ..................1
Primary level ................................2
Secondary level ............................3
University level ............................4
Don‟t know/not sure .................88
Q6. What is your monthly household income from all sources?
Less than K75, 000 ......................1
K75, 000- less than K 200,000 ....2
Over K200, 000............................3
Don‟t know/not sure .................88
Q7. In which year were you diagnosed with HIV infection? ……………………………
Years now
Don‟t know/not sure ...................88
Q8. How many pregnancies have you ever had? ……………….
Don‟t know/not sure ...................88

105

Part II: Cervical Cancer Screening Behavior
Q9. Have you ever had cervical cancer screening (examined for cervical cancer)?
Yes ......................... 1 (Continue Q.10)
No ................................ 2 (go to Q.14)
Don‟t know/not sure ........................88
Q10. If yes, when was the screening (examination) done?
Before HIV diagnosis .......................1
After HIV diagnosis ........................2
Don‟t know/not sure .......................88
Q11. If yes, how often have you been going for screening (examination)?
Every year........................................1
Not every year ................................2
Don‟t know/not sure ......................88
Q12. When did you have your most recent screening (examination)?
Less than year .................................1
More than year ................................2
Don‟t know/not sure ......................88
Ask for a woman’s permission to check for the screening uptake in health passport.
Q13. What was the cervical cancer screening method?
VIA ..................................................1
Pap Smear …………...…………… 2
Other (specify) …………………… 3
Part 111: Knowledge about Cervical Cancer and Screening
A: Risk Factors of Developing Cervical Cancer (Respond to each item)
Q. Do you think the following factors may increase the 1
2
woman’s chance of developing cervical cancer?
14 Smoking
Yes No
15

Having many sexual partners

Yes

No

16

Yes

No

17

Having a sexual partner with many previous sexual
partners
Having a sexual partner who is not circumcised

Yes

No

18

Having sex at an early age

Yes

No

19

Having a weakened immune system (because of
HIV/AIDS)
Infection with HPV (Human Papilloma Virus)

Yes

No

Yes

No

20
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Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure
Do not know/

21

Having sexually transmitted infection

Yes

No

22

Having a family member diagnosed with cancer

Yes

No

23

Inserting traditional medicine into the vagina

Yes

No

24

Taking family planning pills for a long time

Yes

No

25

Having many children

Yes

No

26

Not going for regular screening

Yes

No

Not sure
Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure

B: Signs and Symptoms of Cervical Cancer. (Respond to each item)

27

Do you think the following are signs and symptoms
of cervical cancer?
Vaginal bleeding between periods

28

Menstrual periods that are heavier or longer than usual

29

Vaginal bleeding after the menopause

30

Vaginal bleeding during or after sex

31

Excessive vaginal discharge that smells unpleasant

32

Vaginal itching or irritation

33

Pain or discomfort during sexual intercourse

34

Lower back pain

35

Pelvic pain

36

Frequent urination

37

Unexplained weight loss
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1

2

88

Yes No Do not know/
Not sure
Yes No Do not know/
Not sure
Yes No Do not know/
Not sure
Yes No Do not know/
Not sure
Yes No Do not know/
Not sure
Yes No Do not know/
Not sure
Yes No Do not know/
Not sure
Yes No Do not know/
Not sure
Yes No Do not know/
Not sure
Yes No Do not know/
Not sure
Yes No Do not know/
Not sure

C: Prevention of Cervical Cancer (Respond to each item)
Q

Can the following actions prevent cervical
cancer?
38 Male circumcision

1

2

88

Yes

39 Cervical cancer screening (examining the cervix)

Yes

40 Proper and regular condom use

Yes

41 HPV Vaccination

Yes

No Do not know/
Not sure
No Do not know/
Not sure
No Do not know/
Not sure
No Do not know/
Not sure

D: Awareness about Cervical Cancer, screening and HIV (Respond to each item)

42 A woman who is HIV positive should undergo
cervical cancer screening at least once per year.
43 A woman who is HIV positive is at higher risk of
developing cervical cancer than a woman who is HIV
negative.
44 Cervical cancer develops slowly and can be cured if
detected early

1
Yes

2
No

88
Do not know/
Not sure

Yes

No

Do not know/
Not sure

Yes

No

Do not know/
Not sure

Q45. There is no treatment for cervical cancer?
Yes …………. ………………. 01
No ……………..……………..02
Don‟t know/not sure…………..88
Q46. Is there cervical cancer screening services nearby or at the same location where you are
getting ARVs?
Yes …………. ………………. 01
No ……………..……………..02
Don‟t know/not sure…………...88
Q47. Who performs cervical cancer screening?
Male providers ……………..…. 01
Female providers…………...…..02
Both Male and Female providers.03
Don‟t know/not sure………….....88
Q55. How did you get the information about cervical cancer and screening? (Tick all that
apply)
Family member……………………..01
Friends ………………………….....02
Health care providers………..……..03
Media (radio/TV)……..……………04
Pamphlets/Newspapers …………...05
Others (specify)…………………..06
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Attitude regarding cervical cancer screening (Respond to each item)
Q48. Whom would you be comfortable to perform cervical cancer screening on you?
Male providers………………….1
Female providers……………….2
Both Male and Female providers3
None of the above………………4
Q.
49

50
51

52
53
54

What is your opinion on these questions
1
If an opportunity is given to you to do the
Yes
screening (examination), would you be willing to
do the examination?
Do you fear cervical Cancer screening procedure? Yes

2
No

88
Do not know/
Not sure

No

Do you feel shy to expose your private parts
during the procedure to young or male service
providers?
Are you afraid of pain/discomfort during cervical
cancer screening procedure?
Are you afraid of bleeding during and after
cervical cancer screening procedure?
Are you afraid of being diagnosed with cervical
cancer after undergoing the screening?

Yes

No

Do not know/
Not sure
Do not know/
Not sure

Yes

No

Yes

No

Yes

No

Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure

Part VI: Social Support Networks (Respond to each item)

56
57
58

59
60

61
62

63

Item
Health care providers
Is the health care provider always available when you
need cervical cancer screening services?
Can you share your concerns about cervical cancer
screening with a health care provider?
Have health care providers ever counselled (talked to)
you about cervical cancer screening?
Family members
Does your family try to help you with financial support to
go for cervical cancer screening?
Do you get the emotional help and support you need from
your family regarding HIV and cervical cancer
screening?
Can you discuss about cervical cancer screening with
your family?
Have your family members ever encouraged you to go
for cervical cancer screening?
Friends
Have your friends ever recommended to you cervical
cancer screening?
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1

2

Yes No
Yes No
Yes No

Yes No
Yes No

Yes No
Yes No

Yes No

88
Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure

64
65
66

Can your friends provide social support when found
(diagnosed) with cervical cancer?
Do you have friends with whom you can share your
results of screening (examination)?

Yes No

Can you encourage your friend to go for cervical
screening?

Yes No

Yes No

Do not know/
Not sure
Do not know/
Not sure
Do not know/
Not sure

Part V: Access to cervical cancer screening
Q67. The last time you needed cervical cancer examination, did you get it?
Yes .................................................01
No...................................................02
Do not know/Not sure ...................88
What are the reasons that best explain why you did not get the examination for cervical
cancer? (Respond to each item)

68

Reasons
Affordability
No money for transport

69

Availability
Did not know where to go

Yes

No

70

Screening sites are far (long distance)

Yes

No

71

Accessibility
Previously, I was badly treated

Yes

No

72

Long waiting time

Yes

No

73

Accommodation
The health care providers are inadequate

Yes

No

74

There were no equipment and supplies

Yes

No

75

I thought I was not sick

Yes

No

76

Could not take time off my work/had other
commitments/ laziness

Yes

No
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1

2

88

Yes

No

Do not
know/ Not
sure
Do not
know/ Not
sure
Do not
know/ Not
sure
Do not
know/ Not
sure
Do not
know/ Not
sure
Do not
know/ Not
sure
Do not
know/ Not
sure
Do not
know/ Not
sure
Do not
know/ Not
sure

77

Acceptability
There is no privacy at the clinic

Yes

No

78

Providers are males

Yes

No

79

I do not see the reason to go for screening as I am too
old/too young

Yes

No

Do not
know/ Not
sure
Do not
know/ Not
sure
Do not
know/ Not
sure

Q80. Where did you go for cervical cancer screening?
Government Health facility .....................1
CHAM Health facility .............................2
Private Health facility ..............................3
Q81. How do you travel when going to the clinics (HIV Clinic/cervical cancer screening)?
Public transport ........................................1
Private/own car ........................................2
Bicycle/walk ............................................3
Q82. How long (estimated time) does it take to get to the clinic/examination site from where
you live?
Less than 30 Minutes ...............................1
More than 30Minutes ...............................2

Q83. Any other suggestions on how best cervical cancer screening services would be
improved to increase uptake?
…………………………………………………………………………………………………
…………………………………………………………………………………………………
…………
THE END.
THANK YOU!
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Chichewa
Ndondomeko Yofunsa Mafunso
Kafukufuku ofuna kumva maganizo kwa amayi amene ali ndi kachilombo ka HIV
pakhani yogwiritsa ntchito chithandizo choyezetsa khansa yakhomo la chibelekelo kuno
ku Malawi.

Nthawi yoyambira kuyankha mafunso: [____][____] [____][____] M‟mawa/madzulo
Hour

Minutes

Nambala ya chinsinsi ya pepalali : C_____________.

Dzina la gulu (support group) ndi _____________________________________.

Dera lochokera:
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Tsopano tikufuna kukufusani mafunso amene atithandize kutanthauzira kafukufuku
wathuyu. Mayankho anu adzasungidwa mwachisisi ndipo adzangogwiritsidwa ntchito
pa pakafukufuku yekhayu basi.
Gawo loyamba: Mafunso otsatirawa ndi okhudzana ndi inuyo
Funso 1. Kodi mumagwira ntchito? …………………………………...............................
Ayi sindigwira ntchito ...…….……………...……………01
Eya ndimagwira ntchito (Ntchulani ) …………………

02

Sindikudziwa/ Ndikukayikira..............................................88
Funso 2. Ndinu a chipembedzo chanji?
Chikhirisithu ……………......................................................1
Chisilamu ……......………………………………………...2
Yakho lina (Ntchulani) ............................................................3
Sindikudziwa/ Ndikukayikira ……………….…………………… .....88
Funso 3. Muli ndi zaka zingati?

Zaka…………………
Sindikudziwa/ Ndikukayikira...............................................88

Funso 4. Kodi muli pa banja?
Ayi sindanakwatiwepo ...…….……………...……………01
Eya ndiri pa banja …………………….………………..…02
Banja linatha/ Ndine wamasiye…… ……………………..03
Yakho lina (Ntchulani)………………….…………………04
Funso 5. Kodi sukulu munalekeza kalasi yanji?
Sindinaphunzirepo……………………..…………………01
Pulayimale sukulu...………………………………………02
Sekondale sukulu…………………………………………03
Yunivesite ………………………………………………..04
Sindikudziwa/ Ndikukayikira...……………………………88
Funso 6. Kodi pa khomo panu, mumapeza ndalama zingati pamwezi?
Zochepera K75, 000…………………………………….01
Pakati pa K75 000 osapitilira K200 000 ….…………….02
Kuposera K200 000…………………………………..…03
Sindikudziwa/ Ndikukayikira...………………………….88
Funso 7. Kodi munapezeka ndi kachirombo koyambitsa Edzi mchaka chiti? …………………
Papita zaka .……………………………..
Sindikudziwa/ Ndikukayikira..………………………….88
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Funso 8. Kodi munatengapo mimba kangati? ……………………………………………
Sindikudziwa/ Ndikukayikira...……………………..88
Gawo Lachiwiri: Mafunso otsatirawa ndi okhudzana ndi Kuyezetsa Khansa Yakhomo
la Chibelekelo
A. Zomwe mukuziwapo zokhudzana ndi Khansa Yakhomo la Chibelekelo
Funso 9. Munayamba mwayezedwapo khasa yakhomo lachibelekelo?
Eya ………………………………1(Pitirizani Q.10)
Ayi …………………………………2(Pitani Q. 14)
Sindikudziwa/ Ndikukayikira …………………..88
Funso 10. Ngati mwabvomera, munayezedwa liti?
Ndisanayezetse HIV …..…….………..………….1
Nditayezetsa kale HIV…….……………..………2
Sindikudziwa/ Ndikukayikira ………….………88
Funso 11. Ngati mwabvomera, munayezetsa kangati?
Chaka chirichonse …..…….……………..…..….1
Osati chaka chirichonse ………………….………2
Sindikudziwa/ Ndikukayikira …...............…..…88
Funso 12. Ngati mwabvomera, munayezedwa liti komaliza?
Chaka chisanathe …..…….………………....…….1
Chaka chadutsa ……………………..……….……2
Sindikudziwa/ Ndikukayikira .…………………88
Phephani kuti muwone pamene analemba kuti ayezetsa khasa yakhomo lachibelekelo
Funso 13. Kodi anagwiritsa njira yanji pokuyezani?
VIA ……………………………………………….1
Pap Smear …..…………………………………….2
Njira zina (Ntchulani) …………………………….3
Gawo Lachitatu: Mafunso otsatirawa ndi okhudzana ndi zomwe mukudziwapo za
khansa Yakhomo la Chibelekelo
A. Kodi zinthu IZI zingayambitse khansa yakhomo lachiberekero?
Funso Zinthu

1

2

14

Eya

Ayi Sindikudziwa/
Ndikukayikira

Kusuta
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15

Kugonana ndi athu ochuluka

Eya

Ayi Sindikudziwa/
Ndikukayikira

16

Kugonana ndi mwamuna amene amagonana ndi
anthu ochuluka

Eya

Ayi Sindikudziwa/
Ndikukayikira

17

Kugogana ndi mwamuna osadulidwa

Eya

Ayi Sindikudziwa/
Ndikukayikira

18

Kuyamba kugonana uli wachichepere

Eya

Ayi Sindikudziwa/
Ndikukayikira

19

Kupezeka ndi kachirombo ka HIV

Eya

Ayi Sindikudziwa/
Ndikukayikira

20

Kupezeka ndi kachirombo koyambitsa khansa
ya khomo la chiberekero

Eya

Ayi Sindikudziwa/
Ndikukayikira

21

Kupezeka ndi matenda opatsirana pogonana

Eya

Ayi Sindikudziwa/
Ndikukayikira

22

Zakumtundu

Eya

Ayi Sindikudziwa/
Ndikukayikira

23

Muchitidwe woyika makhwala achikuda
kumasoku

Eya

Ayi Sindikudziwa/
Ndikukayikira

24

Kugwirista ntchito mapiritsi ngati njira yolera

Eya

Ayi Sindikudziwa/
Ndikukayikira

25

Kubereka kwambiri

Eya

Ayi Sindikudziwa/
Ndikukayikira

26

Kusayezetsa khansa lakhomo lachiberekero
pafupi pafupi

Eya

Ayi Sindikudziwa/
Ndikukayikira

Kodi zinthu zosatirazi ndi zizindikiro za
khansa yakhomo la chibelekero?
Kusamba pafupi pafupi

1

2
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Eya

Ayi

Eya

Ayi

29

Kusamba mopitilira komaso kutaya magazi
ambiri posamba
Kuyambiranso kusamba utasiya kaye

Eya

Ayi

30

Kutuluka magazi pogonana

Eya

Ayi

31

Kutuluka chikazi chambira komaso chonukha

Eya

Ayi

32

Kumva kuyabwa kumusi

Eya

Ayi

Sindikudziwa/
Ndikukayikira
Sindikudziwa/
Ndikukayikira
Sindikudziwa/
Ndikukayikira
Sindikudziwa/
Ndikukayikira
Sindikudziwa/
Ndikukayikira
Sindikudziwa/

B. Zizindikiro za khansa yakhomo la chibelekero
Funso
27
28
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Ndikukayikira
Sindikudziwa/
Ndikukayikira
Sindikudziwa/
Ndikukayikira
Sindikudziwa/
Ndikukayikira
Sindikudziwa/
Ndikukayikira
Sindikudziwa/
Ndikukayikira

33

Kumva kupweteka pogonana

Eya

Ayi

34

Kupweteka kwa nsana

Eya

Ayi

35

Kumva kupweteka muchinena

Eya

Ayi

36

Kukodza pafupi-pafupi

Eya

Ayi

37

Kuwonda

Eya

Ayi

1

2

38

Kodi zinthu zosatirazi zingathandize kupewa
khansa yakhomo la chibelekero?
Mudulidwe wa bamboo

Eya

39

Kuyezetsa khansa yakhomo la chibelekero

Eya

40

Kugwiritsa ntchito kondomu moyenera
pogonana
Kulandira katemera wa khansa yakhomo la
chibelekero

Eya

Ayi Sindikudziwa/
Ndikukayikira
Ayi Sindikudziwa/
Ndikukayikira
Ayi Sindikudziwa/
Ndikukayikira
Ayi Sindikudziwa/
Ndikukayikira

C. Kupewa khansa yakhomo la chibelekero
Funso

41

Eya
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D. Zomwe tikudziwapo zankhani yakhansa yakhomo la chibelekero, kuyezesa ndi HIV
Funso
42

43

44

Kodi zithu zosatirazi zingathandize kupewa
khansa yakhomo la chibelekero?
Mai amene ali ndi kachirombo ka HIV ayenera
kuyezetsa Khansa yakhomo lachiberekero chaka
chirichonse
Amayi amene ali ndi kachilombo ka HIV ali pa
chiwopsezo chachikulu chopezeka ndi khansa
lakhomo lachiberekero
Bvuto la Khansa yakhomo lachiberekero
limayamba pang‟onopang‟no ndipo khansa
ndiyochilitsika osati HIV

1

2

88

Eya Ayi Sindikudziwa/
Ndikukayikira
Eya Ayi Sindikudziwa/
Ndikukayikira
Eya Ayi Sindikudziwa/
Ndikukayikira

Funso 45. Kulibe mankhwala a Khansa yakhomo lachiberekero?
Eya ……………………………………1
Ayi ………………………………………2
Sindikudziwa/ Ndikukayikira …………..88
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Funso 46. Kodi pafupi ndi ART clinic, kumene mumalandira makhwala inuyo, Kuli malo
oyedzerako Khansa yakhomo lachiberekero?
Eya ……………………………………1
Ayi ………………………………………2
Sindikudziwa/ Ndikukayikira …………..88
Q. 47. Kodi ndi ndani amayesa khansa yakhomo la chiberekero?
Madokotala amuna ……………………………..1
Madokotala achizimayi ………………………...2
Madokotala onse amuna ndi achizima…………..3
Sindikudziwa/Ndikukayikira ………………….88

Mafunso otsatirawa ndi okhudzana ndi mmene mumayiwonera nkhani yakuyezetsa
Khansa Yakhomo la Chiberekelo
Q. 48. Kodi mukhoza kukhala womasuka ndindani pokuyesani khansa yakhomo la
chiberekero?
Madokotala amuna ……………………………..1
Madokotala achizimayi ………………………...2
Madokotala onse amuna ndi achizima…………..3
Sindikudziwa/Ndikukayikira ………………….88

Funso

Kufuna kumva maganizo anu pa nkhani izi:

1

2

88

49

Kodi mutapatsidwa mwawi wosakha kuti
muyezetse khasa yakhomo la chiberekero,
mungalore?

Eya

Ayi

Sindikudziwa/
Ndikukayikira

50

Kodi muli ndi mantha ndi mmene amayezera
khasa yakhomo la chiberekero?

Eya

Ayi

Sindikudziwa/
Ndikukayikira

51

Kodi mungachite manyazi kukuyezani khansa
yakhomo la chibelekero ndi dokotala
wachichepere kapena wamwamuna?

Eya

Ayi

Sindikudziwa/
Ndikukayikira

52

Kodi mumawopa kukayezetsa chifukwa choti
zimapweteka/ kusowa mtendere poyezetsa/
ankayetsa khansa yakhomo la chiberekero?

Eya

Ayi

Sindikudziwa/
Ndikukayikira

53

Kodi mumawopa kukayezetsa chifukwa choti
mayi amataya magazi poyezetsa khansa
yakhomo la chiberekero?

Eya

Ayi

Sindikudziwa/
Ndikukayikira
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54

Kodi mumawopa kukayezetsa chifukwa choti
mukhoza kupezeka ndi khansa yakhomo la
chiberekero?

Eya

Ayi

Sindikudziwa/
Ndikukayikira

Chigawo lachinayi: Chithandizo chomwe mwakhala mukulandira kuchokela kwa anthu
ena
Q. 55. Kodi munamva kwa ndani za khasa yakhomo la chiberekero ndi kuyezetsa? (Mayakho
angapo atha kuperekedwa)
Azimayi anzanga ……..………………………….01
Kwa a chibale anga…. …………………………..02
Ku Chipatala kwa madokotala ………..…………03
Radio/TV/Wayilesi …. ………………………….04
Ndinawerenga mu news/pepala………………….05
Njira zina (fotokozani) ………………………….06
Tsopano ndikufuna ndikufunseni mafunso okhuzana ndi chithandizo chomwe mwakhala
mukulandira kuchokela kwa anthu.
Item
Significant others
Kodi madokotala amapezeka pamene mukufuna
kuyezetsa khansa la khomo lachiberekero?

1

2

88

Ayi

Eya

Sindikudziwa/
Ndikukayikira

57

Kodi muli ndi dokotala amene mungathe kumuudza
maganizo anu a khansa la khomo lachiberekero?

Ayi

Eya

Sindikudziwa/
Ndikukayikira

58

Kodi madokotala amene amakuthandizani
anakukambiraniponi nkhani yoyezetsa khansa la
khomo lachiberekero?
Family
Kodi abale anu amakuthandizani ndi ndalama kuti
mukayezetse khansa la khomo lachiberekero?
Kodi abale anu amakuthandizani kupeza yakho ya
nkhwawa zanu zokhuzana ndikuyezetsa khansa la
khomo lachiberekero?
Kodi mukhonza kukamba za mavuto anu akhansa la
khomo lachiberekero ndi abale anu?

Ayi

Eya

Sindikudziwa/
Ndikukayikira

Ayi

Eya

Ayi

Eya

Sindikudziwa/
Ndikukayikira
Sindikudziwa/
Ndikukayikira

Ayi

Eya

Sindikudziwa/
Ndikukayikira

Kodi abale anu amakulimbikitsani kuti mupange
chiganizo chokayezetsa khansa la khomo
lachiberekero?
Friends
Kodi anzanu amakhala okonzeka kukuthangatirani
kupanga maganizo okayezetsa khansa la khomo
lachiberekero?
Kodi anzanu akhodza kukuthandizani mutapezeka
ndi khansa la khomo lachiberekero?

Ayi

Eya

Sindikudziwa/
Ndikukayikira

Ayi

Eya

Sindikudziwa/
Ndikukayikira

Ayi

Eya

Sindikudziwa/
Ndikukayikira

56

59
60

61
62

63

64
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65

Kodi muli ndi anzanu omwe mungawauze zosatira
zanu mutayezetsa khansa la khomo lachiberekero?

Ayi

Eya

Sindikudziwa/
Ndikukayikira

66

Kodi mukhonza kuwauza anzanu kuti akayezetse
khansa la khomo lachiberekero?

Ayi

Eya

Sindikudziwa/
Ndikukayikira

Gawo Lachisanu: Mafunso otsatirawa ndi okhudzana ndi zomwe zingalepheletse mai
kukayezetsa Khansa Yakhomo la Chiberekelo
Q. 67. Kodi nthawi imene mumafuna kuyezetsa khasa yakhomo la chiberekero, zinatheka?
Eya …………………………………………….1
Ayi …………………………………………….2
Sindikudziwa/ Ndikukayikira …….…………88
Sankhani zifukwa zomwe zinalepheretsa kuti muyezetse khasa yakhomo la chiberekero
Funso Zifukwa
Affordability
68
Kusowa ndalama zoti ndiyendere (transport)

1

2

Eya

Ayi Sindikudziwa/
Ndikukayikira

Eya

Ayi Sindikudziwa/
Ndikukayikira
Ayi Sindikudziwa/
Ndikukayikira

70

Availability
Sindikudziwa komwe amayezetsa khasa yakhomo
la chiberekero
Zipatala zoyetsa khasa zili kutali

71

Accessibility
Achipatala sanandisamalire bwino

Eya

72

Timadikira nthawi yayitali

Eya

69

Eya

88

Ayi Sindikudziwa/
Ndikukayikira
Ayi Sindikudziwa/
Ndikukayikira

Accommodation
73

Eya

75

Kulibe madokotala woyeza khasa yakhomo la
chiberekero
Kunalibe zipangizo zoyezera khasa yakhomo la
chiberekero
Sindikudwala

76

Ndimasowa nthwawi/mpata

Eya

77

Acceptability
Kulibe chinsinsi ku chipatala

Eya

78

Madokotala ndi amuna

Eya

79

Sindikuwona chifukwa chokayezetsera khasa
yakhomo la chiberekero chifukwa ndine
wamkulu/mwana

Eya

74

119

Eya
Eya

Ayi Sindikudziwa/
Ndikukayikira
Ayi Sindikudziwa/
Ndikukayikira
Ayi Sindikudziwa/
Ndikukayikira
Ayi Sindikudziwa/
Ndikukayikira
Ayi Sindikudziwa/
Ndikukayikira
Ayi Sindikudziwa/
Ndikukayikira
Ayi Sindikudziwa/
Ndikukayikira

Q. 80. Kodi munakayezetsa kuti khasa yakhomo la chiberekero?
Kuchipatala cha boma ………………………...….1
Kuchipatala cha mission ………………………….2
Kuchipatala cholipira ……………………………..3

Q81. Kodi mmayenda bwanji mukamapita ku clinic ya HIV kapena ya Khansa?
Ndimakwera minibasi ………………………...….1
Ndimapita pa galimoto yathu…………………….2
Ndimakwera njinga/ndimayenda ………………..3
Q82. Kodi mmatenga nthawi yotalika bwanji kukafika ku clinic ya HIV kapena ya Khansa
kuchokera kumene mumakhala?
Mphindi zochepera makumi atatu…………...….1
Mphindi zopitirira makumi atatu…………....…. 2
Q83. Kodi mungakhale ndi maganizo ena othandiza kupititsa mtsogolo nkhani yoyezetsa
khasa yakhomo la chiberekelo?
…………………………………………………………………………………………………
…………………………………………………………………………………………………

MAFUNSO ATHERA PAMENEPA.

ZIKOMO!
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H. RECRUITMENT ANNOUNCEMENT
English
……………….………….

SUPPORT GROUP

Research Opportunity: Views about Cervical Cancer Examination
Period: August- December 2017


If you are a woman aged 18 or more, there will be a research to hear your views about
cervical cancer examination by Mrs Mtengezo who is studying her degree at the
University of Massachusetts Boston.



The study will help to develop ways of preventing cervical cancer and live a quality
life.



The interview will be done at your support group meeting place at your convenient
time and language on your agreed dates.



The interview will last approximately 30-45 minutes and transport will be provided.



Your participation in this study is confidential and the decision whether to take part in
this research study is voluntary.



You are free to withdraw from the study at any time. The decision to participate or not
in this study will not affect your healthcare services.



If you are interested or you have any questions about the study, please contact:
o Mrs Jasintha Mtengezo on (+265) 0888863080 anytime of the day.
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Chichewa
CHIDZIWITSO CHA KUFUNA ANTHU KUCHITA NAWO KAFUKUFUKU
……………….………….

SUPPORT GROUP

KAFUKUFUKU: MAGANIZO ANU PA ZAKUYEZETSA KHANSA YAKHOMO LA
CHIBEREKERO
Nthawi ya Kafukufuku: August mpaka December 2017.


Ngati ndinu mayi wa zaka 18 kapena kupitilira, kudzchitika kafukufuku wofuna
kumva maganizo anu pankhani oyezetsa khansa la khomo la chiberekero ndi mai
Mtengezo amanene akuchita maphunziro awo ku Amereka.



Kumwa maganizo anu kudzathandiza kupeza njira zolimbikitsira kuyezetsa khansa
lakhomo lachiberekero pofuna kupewa khansayi ndi kukhala ndi umoyo wabwino.



Kucheza nanu kudzachitikira kumene mumakumana ngati gulu panthawi yomwe ndi
yabwino kwa inu komanso mchilankhulo chomwe mungakonde.



Kucheza nanu kudzatenga mphindi pakatikati pa makhumi atatu (30) ndi makumi
anayi ndi asanu (45) ndipo mudzabwezeretsedwa ndalama zamayendedwe.



Kutengako gawo kwanu mukafukufukuyu kudzakhala kwa chinsinsi ndipo
mudzakhala omasuka kupanga nawo kapena ayi.



Mudzakhala omasuka kusiya kuchita nawo zokambilana nthawi ina ili yonse. Ndipo
chiganizo chanu chakuchita nawo kapena kusachita nawo sikudzakhudza thandizo
lanu lomwe mumapeza ku chipatala.



Ngati mwasangalatsidwa kuchita nawo kafukufukuyu kapena muli ndi mafunso ena,
kumanani ndi:
o Mai Mtengezo poyimba foni pa nambala iyi: (+265) 888863080 nthawi ina ili
yonse.
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I. SEEKING PERMISSION LETTERS
Lilongwe City Council (Urban) Office
University of Massachusetts Boston
Daeyang College of
Nursing
Department of Nursing
P.O. Box 30330
100 Morrissey Boulevard Boston, MA. 02125-3393
Lilongwe
March, 2017
The Chief Executive Officer
P.O. Box 30396
Lilongwe City, Malawi
Dear Sir/Madam,
APPLICATION TO CONDUCT A STUDY
I write to seek permission to use the Register for HIV support groups in Lilongwe City to
randomly select 7 HIV support groups to participate in my study should my proposal be
approved by the National Health Sciences Research Committee (NHSRC).
I am a Doctoral student at the University of Massachusetts Boston and Faculty member at
Daeyang College of Nursing. I am planning to conduct a study entitled: “Knowledge and
Attitudes Regarding Cervical Cancer Screening among Women Living with HIV/AIDS
in Malawi: A Cross-sectional Study” in partial fulfillment of the requirements for the
Degree of Doctor of Philosophy in Nursing.
The study will invite a minimum of 280 HIV-positive women aged 18 and above from
randomly selected HIV support groups in Lilongwe City to participate in the study. Women
will answer the health survey questions about knowledge and attitudes regarding cervical
cancer and screening behavior. The study specific aims include:
Specific Aim 1: To describe the status of cervical cancer screening behavior, knowledge and
attitude among Malawian women living with HIV infection.
Specific Aim 2: To explore factors associated with cervical cancer screening behavior among
Malawian women living with HIV infection.
The study involves no more than minimal risk but some questions may be discomforting to
participants and that answering them may make them tired. There are no direct benefits in
participating in this study but the results of the study will provide valuable insights for
informing targeted educational interventions to prevent cervical cancer among this at-risk
population.
Looking forward to your favorable response.
Sincerely,

---------------------------------------------------Mrs. Jasintha Mtengezo (PhD Candidate)
Chair)
Jasintha.Mtengezo001@umb.edu
+265 888 863 080 (Malawi)

-----------------------------------Dr. Haeok Lee (Dissertation
Haeok.Lee@umb.edu
+1 720 220 4018 (USA)
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Lilongwe District Council (Rural) Office
University of Massachusetts Boston
Nursing
Department of Nursing
100 Morrissey Boulevard Boston, MA. 02125-3393

Daeyang College of
P.O. Box 30330
Lilongwe
March, 2017

The District Commissioner
Lilongwe District Council
P.O. Box 93
Lilongwe, Malawi
Dear Sir/Madam,
APPLICATION TO CONDUCT A STUDY
I write to seek permission to use the Register for HIV support groups in Lilongwe District
Council Office to randomly select 5 HIV support groups to participate in my study should my
proposal be approved by the National Health Sciences Research Committee (NHSRC).
I am a Doctoral student at the University of Massachusetts Boston and Faculty member at
Daeyang College of Nursing. I am planning to conduct a study entitled: “Knowledge and
Attitudes Regarding Cervical Cancer Screening among Women Living with HIV/AIDS
in Malawi: A Cross-sectional Study” in partial fulfillment of the requirements for the
Degree of Doctor of Philosophy in Nursing.
The study will invite a minimum of 200 HIV-positive women aged 18 and above from
randomly selected HIV support groups in Lilongwe District to participate in the study.
Women will answer the health survey questions about knowledge and attitudes regarding
cervical cancer and screening behavior. The study specific aims include:
Specific Aim 1: To describe the status of cervical cancer screening behavior, knowledge and
attitude among Malawian women living with HIV infection.
Specific Aim 2: To explore factors associated with cervical cancer screening behavior among
Malawian women living with HIV infection.
The study involves no more than minimal risk but some questions may be discomforting to
participants and that answering them may make them tired. There are no direct benefits in
participating in this study but the results of the study will provide valuable insights for
informing targeted educational interventions to prevent cervical cancer among this at-risk
population.
Looking forward to your favorable response.
Sincerely,

---------------------------------------------------Mrs. Jasintha Mtengezo (PhD Candidate)
Chair)
Jasintha.Mtengezo001@umb.edu
+265 888 863 080 (Malawi)

-----------------------------------Dr. Haeok Lee (Dissertation
Haeok.Lee@umb.edu
+1 720 220 4018 (USA)
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University of Massachusetts Boston
University of Massachusetts Boston
Nursing
Department of Nursing
100 Morrissey Boulevard Boston, MA. 02125-3393
Africa.

Daeyang College of
P.O. Box 30330
Lilongwe, Malawi.
June, 2017.

Dear Sir,
APPLICATION FOR ETHICAL CLEARANCE
I kindly request your clearance for me to conduct my proposed study in Malawi in partial
fulfillment of the requirements for the Degree of Doctor of Philosophy in Nursing.
I am a Doctoral candidate at the University of Massachusetts Boston and Faculty member at
Daeyang College of Nursing in Malawi. I am planning to conduct a study entitled:
“Knowledge and Attitudes Regarding Cervical Cancer Screening among Women Living
with HIV/AIDS in Malawi: A Cross-sectional Study”
Please note that the National IRB in Malawi approves student protocols after the protocol has
been approved by the student‟s training institution. The study participants are HIV-positive
women aged 18 and above. Women will answer the health survey questions about knowledge
and attitudes regarding cervical cancer and screening behavior and they will also be asked to
verify record of cervical cancer screening status. The specific aims of the study include:
Specific Aim 1: To describe the status of cervical cancer screening behavior, knowledge and
attitude among Malawian women living with HIV infection.
Specific Aim 2: To explore factors associated with cervical cancer screening behavior among
Malawian women living with HIV infection.
The study involves no more than minimal risk but some questions may be discomforting to
participants and that answering them may make them tired. There are no direct benefits in
participating in this study but the results of the study will provide valuable insights for
informing targeted educational interventions to prevent cervical cancer among this at-risk
population.
Looking forward to your favorable response.
Sincerely,

------------------------------------------------Mrs. Jasintha Mtengezo (PhD Candidate)
Chair)
Jasintha.Mtengezo001@umb.edu
+265 888 863 080 (Malawi)

----------------------------------------Dr. Haeok Lee (Dissertation
Haeok.Lee@umb.edu
+1 720 220 4018 (USA)
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National Health Sciences Research Committee (NHSRC)
University of Massachusetts Boston
Nursing
Department of Nursing
100 Morrissey Boulevard Boston, MA. 02125-3393

Daeyang College of
P.O. Box 30330
Lilongwe
July, 2017.

National Health Sciences Research Committee
Ministry of Health
P.O. Box 30377, Lilongwe 3
Malawi.
Dear Sir,
APPLICATION FOR ETHICAL CLEARANCE
I kindly request your clearance for me to conduct my proposed study in partial fulfillment of
the requirements for the Degree of Doctor of Philosophy in Nursing.
I am a Doctoral student at the University of Massachusetts Boston and Faculty member at
Daeyang College of Nursing. I am planning to conduct a study entitled: “Knowledge and
Attitudes Regarding Cervical Cancer Screening among Women Living with HIV/AIDS
in Malawi: A Cross-sectional Study.” The protocol has already been approved by my
training institution, University of Massachusetts Boston as per attached documents.
This study involves HIV-positive women aged 18 and above. Women will answer the health
survey questions about knowledge and attitudes regarding cervical cancer and screening
behavior and they will also be asked to verify their cervical cancer screening status. The
specific aims of the study include:
Specific Aim 1: To describe the status of cervical cancer screening behavior, knowledge and
attitude among Malawian women living with HIV infection.
Specific Aim 2: To explore factors associated with cervical cancer screening behavior among
Malawian women living with HIV infection.
The study involves no more than minimal risk but some questions may be discomforting to
participants and that answering them may make them tired. There are no direct benefits in
participating in this study but the results of the study will provide valuable insights for
informing targeted educational interventions to prevent cervical cancer among this at-risk
population.
Looking forward to your favorable response.
Sincerely,

------------------------------------------------Mrs. Jasintha Mtengezo (PhD Candidate)
Chair)
Jasintha.Mtengezo001@umb.edu
+265 888 863 080 (Malawi)

----------------------------------------Dr. Haeok Lee (Dissertation
Haeok.Lee@umb.edu
+1 720 220 4018 (USA)
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J. PERMISSION LETTERS
Lilongwe District Council (Rural) Office
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Lilongwe City Council (Urban) Office
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University of Massachusetts Boston
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National Health Research Council Malawi
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